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 Individuals with Sjögren’s Syndrome (SS) have autoimmune symptoms causing 
systemic dryness.  The disease purportedly affects voice and swallowing function.  
However, little is known regarding the true prevalence of voice and swallowing problems 
and symptoms in SS and their effects on quality of life.  This preliminary epidemiological 
investigation aimed to (1) assess the prevalence of voice and swallowing problems in SS, 
(2) identify risk factors for voice and swallowing problems in SS, and (3) better 
understand the functional, social, occupational, and emotional effects of voice and 
swallowing problems in SS.  One hundred and one individuals with SS (7 males, 94 
females; mean age 59.4, SD = 14.1) were interviewed using an extensive questionnaire.  
Questions surrounding the individual’s medical, psychosocial, occupational, and 
social/lifestyle history, as well as voice and swallowing symptoms, SS severity, and 
health-related quality of life, were explored.  The results were analyzed using summary 
statistics, chi-square tests, risk ratios, and confidence intervals (p < .05).  Of the 101 
individuals with SS, 59.4% reported a current voice disorder and 64.4% reported a 
current swallowing disorder.  These disorders began gradually, were chronic, and 
correlated with SS disease severity.  These results indicated that voice and swallowing 
problems are relatively common in SS and are more frequent as disease severity worsens.  
Voice symptoms, including frequent throat-clearing, chronic throat soreness, difficulty 
projecting the voice, and discomfort with voice use, were significantly correlated with
iv 
 
 health-related quality of life; chronic throat dryness, a monotone voice, a wobbly or 
shaky voice, and chronic throat soreness were significantly associated with SS disease
 severity.  Swallowing symptoms, including difficulty swallowing medications, sneezing 
with eating, wheezing after eating, food sticking in the throat, increased mucous in throat, 
and taking smaller bites for safety were correlated with health-related quality of life; 
taking smaller bites, mucous in throat, difficulty placing food in the mouth, and wheezing 
while eating were significantly associated with SS disease severity.  However, only 
15.8% with voice disorders and 42% with swallowing disorders sought treatment for 
these symptoms.  These findings have implications for evaluation and treatment 
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 The capacity for oral communication and swallowing are central to human health 
and well-being.  These behaviors, both of which share a common anatomy may be 
adversely affected by numerous disease states.  Damage to this shared anatomy may 
result in the loss of two behavioral sets that are central to the human experience, namely 
voice and swallowing. Autoimmune diseases are associated with the body’s inappropriate 
defense against its own healthy tissue and, consequently, may affect voice and 
swallowing function.  Sjögren’s Syndrome (SS) is one such disease.  This study aims to 
examine the epidemiology of voice and swallowing disorders in individuals with this 




Chambers (2004) and Kassan and Moutsopoulos (2004) have described SS as an 
autoimmune disease characterized by systemic dryness, also known as sicca.  Sicca 
symptoms occur most notably in the eyes, mouth, throat, skin, and vagina.  There are two 
forms of SS: primary and secondary.  In general, primary SS is defined as occurring in 
the absence of another inflammatory autoimmune disease.  Secondary SS occurs with—
or secondary to—other autoimmune diseases and is more prevalent than primary SS 
(roughly 60% of cases).  However, the primary versus secondary distinction does not 





secondary SS may experience sicca symptoms as severe as those of primary SS.  As 
reported by Vitali et al. (2002), at least four of the following six criteria must be met for a 
diagnosis of SS: (1) symptoms of dry eye, (2) signs of dry eye, (3) symptoms of dry 
mouth, (4) positive tests of salivary gland dysfunction, (5) positive salivary gland biopsy, 
and/or (6) autoantibodies SS-A or SS-B.  Additionally, one of these criteria must be 
biopsy or blood sample positive for containing autoantibodies.  It is noteworthy, 
however, that the diagnostic criteria and testing techniques for SS remain topics of 
discussion in the rheumatic disease medical community.  These diagnostic considerations 
have the potential to modify criteria for assigning the SS diagnosis, as well as possibly 
increasing recognition of patients with subclinical or early forms of the disease (Cornec 
et al., 2013; Goules, Tzioufas, & Moutsopoulos, 2014).  SS is slowly progressive, has no 
cure, and is treated symptomatically with medication, moistening agents as well as 
inhaled lubricants, and other therapies, such as lifestyle modifications for co-occurring 
laryngopharyngeal reflux (Belafsky & Postma, 2003; Hilgert, Toleti, Kruger, & Nejedlo, 
2006; Kasama et al., 2008; Lee, Fang, & Li, 2002; Rhodus & Bereuter, 2000; Seitsalo et 
al., 2007; Strietzel et al., 2011; Tanner et al., 2013).    
The etiology of SS is unknown, although it may involve genetics, hormones, 
and/or viral components (Mathews, Kurien, & Scofield, 2008).  SS occurs most often in 
perimenopausal women, but it sometimes occurs in men and younger adults and 
teenagers (Skalova, Minxova, & Slezak, 2008).  It is diagnosed in approximately 1% of 
the adult population.  However, it is likely underdiagnosed as SS symptoms are similar to 
symptoms of other health conditions, particularly those related to menopause and aging, 





symptoms affect not only skin and bodily orifices but also the function of other 
connective tissue, internal organs, and digestion (Sjögren’s Syndrome Foundation, 1998).   
Reported laryngeal manifestations common to SS include bamboo nodules, 
esophageal reflux, laryngopharyngeal reflux, and cricoarytenoid arthritis.  However, a 
recent study conducted by our group suggests that individuals with primary SS do not 
experience significant laryngeal structural or mucosal changes—other than dryness—and 
that in cases of secondary SS these changes may be more related to the primary disease 
process, such as rheumatoid arthritis or lupus (Heller et al., 2013). Individuals with SS 
also have auditory-perceptual features of dysphonia characterized by hoarseness, 
breathiness, and strain, as well as auditory-perceptual and acoustic severity values in the 
mild to mild-to-moderate range (Doig et al., 1971; Heller et al., 2013; Ogut et al., 2005; 
Ruiz Allec et al., 2011).  Additionally, individuals with SS experience dysphagia due to 
reduced saliva and esophageal abnormalities (Belafsky & Postma, 2003; Bitter, Volk, 
Lehmann, Wittekindt, & Guntinas-Lichius, 2011; Caruso, Sonies, Atkinson, & Fox, 
1989; Doig et al., 1971; Hilgert et al., 2006; Murano et al., 2001; Ruiz Allec et al., 2011; 
Seve, Poupart, Bui-Xuan, Charbon, & Broussolle, 2005; Skalova et al., 2008).  Other 
major health issues include Raynaud’s phenomenon (Seitsalo et al., 2007), neurologic 
components (Cheung, Chen, Hsin, Tsai, & Leong, 2010; Michel et al., 2011), chronic 
fatigue (Ng & Bowman, 2010), non-Hodgkin’s lymphoma (Lee et al., 2002; Theander et 
al., 2011), and various oral manifestations such as dental caries, loss of teeth, and 
articulatory changes (Heller et al., 2013; Mathews et al., 2008; Ruiz Allec et al., 2011).  
Besides sicca symptoms, factors contributing to voice and swallowing disorders in SS 





gastroesophageal reflux (Belafsky & Postma, 2003; Cheung et al., 2010; Prytz, 1980), to 
name a few.    
Only a few studies exist that have examined the frequency of voice and 
swallowing problems in SS, and these indicate somewhat conflicting observations.  Table 
1 summarizes and critiques studies from the literature reporting epidemiological data for 
voice and swallowing disorders in SS.  (Note. Single case studies/reports are not included 
in Table 1.)  Most of the studies in Table 1 include typical signs and symptoms of voice 
and swallowing dysfunction.  Though each of these studies provides important insight 
into effects of SS, none include a thorough analysis of the epidemiology of voice and 
swallowing disorders in SS.  Common weaknesses include a small sample size, a lack of 
specificity regarding disease history and severity, a limited discussion of the specific 
contributing factors of disorders, a limited discussion of socioemotional effects of voice 
and swallowing symptoms, and the absence of psychometrically validated voice and 
swallowing measures.   
Perhaps the largest and most relevant study examining voice and swallowing 
disorders in SS was conducted by Ruiz Allec et al. (2011).  This group examined voice, 
swallowing, and speech dysfunction in SS using subjective and objective measures and 
discussed prevalence of each of these areas of dysfunction.  However, this study included 
a relatively small group (n = 31), only two of whom had primary SS, and provided only a 
limited discussion of the risk factors that might contribute to the presence of voice and 
swallowing problems in this population.  Additionally, limited information was provided 
by the authors regarding the potential adverse effects of these disorders on 






Table 1. Characteristics of studies examining voice and swallowing dysfunction in SS 
Study 
(chronologically) 
# of Subjects Gender 
Representation 
Age Methods Findings Weaknesses/ Limitations 
“Otolaryngological 
aspects of Sjögren’s 























Dysphagia: pSS 27.3%, 
SS+RA 32.3%, RA 9.5%; 
 
Hoarseness: pSS 27.3%, 
SS+RA 19.4%, RA 9.5% 
Small n, gender not specified, 
limited patient history/symptom 
review, hoarseness is only voice 
symptom noted, no discussion of 
socioemotional effects 
“Objective measures 
of swallowing in 
patients with primary 
Sjögren’s syndrome” 
Caruso et al., 1989 
34 pSS 
 
34 controls  
Not specified 32–72  
mean 55 
Salivary function via 
saliva collection, real-





pSS: longer dry swallows 
and 40% had longer water 
bolus swallows than dry 
swallows; salivary gland 
dysfunction alone can cause 
dysphagia 
Small n, gender not specified, only 
measured swallow times and 
included few other swallow 
complaints, did not analyze voice 
dysfunction, no discussion of 
socioemotional effects  
“Quantitative 
assessment of 
dysphagia in patients 
with primary and 
secondary Sjögren’s 
syndrome” Rhodus, 
Colby, Moller, & 
Bereuter, 1995 
 
13 pSS  
 
15 sSS+SLE  
 
14 controls 





pSS: 54.5 ± 3.4 
 
sSS+SLE: age 
57.4 ± 2.5 
 
controls: 56.3 ± 
4.4 
Oral exam, oral and 






SS and SLE: significant 
dysphagia  
 
sSS+SLE: more severe 
except in pharyngeal transit 
time with a water bolus 
Small n, specific prevalence not 
reported, no voice symptoms 









96 pSS  Not specified in 
abstract 
Not specified in 
abstract 
Clinical and laboratory 
diagnostic criteria 
71% had hoarse voice Article in Norwegian, only voice 
symptom reported was hoarseness, 
no report of contributing factors, 
no report of swallowing 








Table 1. Continued 
Study 
(chronologically) 
# of Subjects Gender 
Representation 
Age Methods Findings Weaknesses/ Limitations 




of a multidisciplinary 
clinic” Freeman, 


























of salivary glands and 
neck 
Discrepancy between 
symptoms and abnormal 
exam: pSS 79%/27%, sSS 
17%/5%, sicca 34%/7%, 
average 60–70%/20% 
Not age/sex-matched, only voice 
symptoms specified were chronic 
pharyngitis or laryngitis, no 
discussion of swallowing, no 
discussion of socioemotional 
effects 
“Laryngeal findings 
and voice quality in 
Sjögren’s syndrome” 




SS: 70F 7M 
 




Reflux Symptom Index, 
Reflux Finding Score, 







Findings of reflux in SS was 
statistically significant, 
significant association 
between SS and variety of 
other laryngeal pathologies  
Did not specify if participants were 
pSS or sSS, did not include 
swallowing measures, only named 
reflux as potential cause of 
pathologies, no discussion of 
severity or socioemotional effects 
“Dysphagia and 
















54.5 mean 48 
 






nervous function tests 
 
pSS: 65% dysphagia, 60% 
GERD, 45% pharyngeal 
swallowing symptom, 80% 
oesophageal swallowing 
symptom, sensory 
dysfunction may contribute 
to dysphagia 
Small n, no pt history gathered to 
determine potential causes, no 
discussion of voice, no discussion 








Table 1. Continued 
Study 
(chronologically) 
# of Subjects Gender 
Representation 
Age Methods Findings Weaknesses/ Limitations 





Ruiz Allec et al., 
2011 
31 SS: 4pSS 
27sSS 











Reported: 41.94% voice 
problems, 48.38% gastritis 
and/or GERD, 38.7% speech 
problems, 70.9% dysphagia 
 






bands, 48.38% glottal 
closure defect, 90.32% 
altered rippling of the VF 
mucosa, 90.32% swallowing 
disorders, 90.32% 
abnormalities in 
voice/speech analysis, 9.68% 
dysarthria  
 
Small n, limited discussion of 
causes, limited discussion of 
severity and socioemotional effects 
“Effects of reduced 







20 SS: 10p 
10s 
 
20 controls  




30–74 12-item questionnaire 
of perception of dry 
mouth and swallowing 
abilities, stimulated 
saliva production, FEES 
SS: generally perceived their 
swallowing impairment but 
97% of swallows were 
functional and only 3% 
aspiration   
Small n, excluded pts w/no 
complaints of dry mouth, no 






Table 1. Continued 
Study 
(chronologically) 
# of Subjects Gender 
Representation 
Age Methods Findings Weaknesses/ Limitations 












44 RA, 32 
SLE, 4 SS 
60 controls 


















dysphonia; voice disorders in 
SS no significant prevalence; 
voice disorders 81% worse 
during flare; steroids, voice 
rest, and speech therapy are 
suggested treatments; quality 
of life reduced due to voice 
disorders 
Small n in SS subgroup, 
unbalanced gender %, gender/age 
not specified for RA/SLE/SS, 
swallowing not studied 
Note. pSS = primary SS; sSS = secondary SS, SLE = systemic lupus, GRBAS = Grade/Roughness/Breathiness/Asthenia/Strain, FEES = fiberoptic endoscopic evaluation of 






The current and lifetime prevalence of voice disorders in the general adult 
population is 6.6% and 29.9%, respectively, and voice disorders are strongly associated 
with sex, age, voice use patterns and demands, esophageal reflux, chemical exposures, 
and frequent cold/sinus infections (Roy, Merrill, Gray, & Smith, 2005).  By comparison, 
it is reported that the prevalence of current voice disorders in SS ranges dramatically 
from 12% to 41.9% (Ruiz Allec et al., 2011; Sanz et al., 2011).  The prevalence of 
current swallowing disorders in the general adult population is 12–13% (Groher & 
Bukatman, 1986).  Reports on the prevalence of swallowing disorders in SS range from 
32% to 70.9% (Doig et al., 1971; Ruiz Allec et al., 2011).  Some assert that these 
symptoms may be related to sensory deficits (Rogus-Pulia & Logemann, 2011).  Based 
upon these results, it appears that voice and swallowing problems are more common in 
SS as compared to the general population, but the true prevalence in SS remains 
undetermined. 
While it appears obvious that SS has a significant impact on an individual’s health 
and well-being, little is known regarding (1) the prevalence of voice and swallowing 
disorders in SS, (2) patterns of voice and swallowing decline in SS, (3) risk factors 
associated with this decline, and (4) consequences of voice and swallowing disorders on 




Epidemiology is the study of the relationships of various factors determining the 
frequency and distribution of diseases and disorders in a population.  At present, the true 
prevalence of voice and swallowing disorders in SS is undetermined.  This descriptive, 
10 
 
    
 
epidemiological investigation interviewed a sample of patients with SS to provide much 
needed data regarding voice and swallowing disorders associated with these autoimmune 
conditions.  There were three specific aims related to this study: (1) to provide data 
regarding the prevalence of voice and swallowing disorders in the SS population, (2) to 
identify risk factors for voice and swallowing disorders in SS, and (3) to better 
understand the functional, social, occupational, and emotional effects of voice and 














 Participants included 101 adult (age 18+) individuals identified and recruited from 
the SS population.  A 3-year retrospective chart review of patients from the Division of 
Rheumatology at University Hospital, University of Utah Health Care was undertaken in 
the fall of 2012 using diagnosis codes associated with this disease.  Medical records were 
reviewed to verify diagnosis.  Criteria for SS diagnosis included clinical presentation of 
sicca symptoms, positive SS-A or SS-B antibodies, and/or positive minor salivary gland 
findings from lip biopsy (Chambers, 2004; Kassan & Moutsopoulos, 2004).  
 Consecutive patients with SS diagnosis were identified and invited to participate 
until at least 100 participants were enrolled.  Inclusion criteria were the diagnosis of SS, 
age 18 or older, English-speaking, adequate hearing for purposes of the telephone 
interview, and no known or reported cognitive deficits.  Primary SS was the target 
population; however, when 100 participants with primary SS could not be identified, 
secondary SS was also included.  It should be noted that autoimmune diseases often 
coexist.  Because one of the purposes of this study was to sample the range and variety of 
voice and swallowing symptoms experienced by individuals with SS, individuals were 
not excluded on the basis of other health conditions, diagnoses, or diseases.  The chart 
review identified 160 eligible participants who were subsequently invited to participate.  




    
 
 
101 individuals with SS, or 63% of eligible participants.   
 Participant recruitment procedures included written correspondence and a 
subsequent telephone call.  Individuals received a letter indicating that they would 
receive a call regarding possible study participation and that they might opt out of the call 
by contacting the principal investigator by phone or in writing.  The envelope included 
two copies of the consent form and a postage-paid return envelope.  Within a 2-week 
period, individuals received a telephone call by a co-investigator, providing details about 
the study and inviting them to participate.  If the individual was interested in 
participating, the consent form was reviewed via telephone, and a signed copy was 
returned to the investigators.  A time for telephone administration of the survey was 
scheduled, allowing time for return of the consent form.  Once the signed consent form 
was received, the survey was administered via telephone.  The participant was instructed 
that she or he could choose to withdraw from the study and cancel the telephone survey at 
any time.  Interviews were conducted over a 6-month period between fall of 2012 and 
winter of 2013 by graduate and undergraduate students in the Department of 
Communication Sciences and Disorders at The University of Utah.  This study was 




 The survey instrument used in the present investigation included a 
comprehensive, 45-item survey involving medical, lifestyle, psychosocial, and 
occupational factors, voice and swallowing symptoms, and individual disease severity 




    
 
 
voice does not work, perform, or sound as it normally should, so that it interferes with 
communication” (Roy et al., 2005, p. 1989).  This definition of a voice disorder was 
previously used in the largest National Institutes of Health epidemiology study of voice 
disorders in the U.S. (R01 DC02285 Elaine Smith, Principal Investigator, National 
Institute on Deafness and Other Communication Disorders).  Similarly, a swallowing 
disorder was considered to be “any time an individual experiences difficulty moving food 
or liquid from mouth to stomach, or experiences choking or throat clearing during or 
following mealtime” (Roy, Stemple, Merrill, & Thomas, 2007b, p. 859).  This is the 
conventional definition of a swallowing disorder employed in applied research and in 
contemporary texts dedicated to the topic of dysphagia.  Thus, the survey probed the 
domains of both voice and swallowing history to identify symptoms and signs, practices 
and patterns, and relate these findings to medical, psychosocial, occupational, and social 
and lifestyle factors.  The survey required approximately 75 minutes to complete.  The 




 Voice production and swallowing function are influenced by a variety of medical 
conditions.  We selected 21 disorders with the potential to influence the structures and/or 
function of voice and swallowing. We considered the presence or absence of these 
conditions in the participant’s lifetime and, if appropriate, mechanisms of medical 
treatment.  The inclusion of the 21 disorders was based upon the examination of 
previously employed surveys, a review of current literature (Roy et al., 2005; Roy, 




    
 
 
clinical experience of the investigators.  This section also included more detailed 




 Psychosocial factors may contribute to and be affected by voice and swallowing 
disorders (Roy, Stemple, Merrill, & Thomas, 2007a; Roy et al., 2007b).  This section of 
the survey probed two main areas within the psychosocial domain, including 
psychosocial risk factors, such as gender and activity level, as well as the psychosocial 
impact of voice and swallowing disorders.  Three standardized batteries, the Voice-
Related Quality of Life (V-RQOL; Hogikyan & Sethuraman, 1999), the M.D. Anderson 
Dysphagia Inventory (MDADI; Chen et al., 2001), and the Short Form 36 Health Survey 
(SF-36; Ware, Gandek, & International Quality of Life Assessment Project Group, 1994) 
were included to comprehensively examine the impact of voice and swallowing disorders 
and general health on this population.  The MDADI is a psychometrically validated, 
dysphagia-specific instrument that assesses psychosocial aspects of dysphagia.  The V-
RQOL is a validated, reliable, 10-item instrument that has been used to determine the 
impact of voice impairment on quality of life and as an outcome measure in patients with 
voice disorders.  The SF-36 is a psychometrically validated survey.  The SF-36 was 
developed to assess eight different measures of functional health and well-being and 
psychometrically based physical and mental health; that is, four scales reflect different 
dimensions of physical health and four scales reflect different dimensions of mental 
health.  The SF-36 is a generic tool in that it does not target a specific age, disease, or 




    
 
 
populations, comparing the relative burden of eight profiles (physical functioning, bodily 
pain, role limitations due to physical health problems, role limitations due to emotional 
problems, emotional well-being, social functioning, energy/fatigue, and general health 
perceptions).  An additional question involving how the participant felt on a daily basis 
was also included. 
 
 
Occupational or Employment History 
 Research has identified a link between occupation and the risk of voice disorders 
(Roy et al., 2005; Roy, Merrill, Thibeault, Gray, et al., 2004; Roy, Merrill, Thibeault, 
Parsa, et al., 2004); however, the relationship between occupation and swallowing 
problems has not been documented.  This survey examined aspects of the participant’s 
occupational history in order to determine its potential role in voice symptomology.  This 
section examined work history, job related voice use patterns, and the participant’s 
perception of the impact of job-related voice use on voice production.  
 
 
Social and Lifestyle History 
 Lifestyle patterns and choices may influence voice and swallowing (Roy et al., 
2005; Roy et al., 2007a, 2007b).  Diet may influence these processes via its impact on 
hydration and on levels of harmful stomach acid refluxing into the larynx and pharynx.  
The use of tobacco products, alcohol, and recreational drugs may also influence function 
by altering the hydration and integrity of tissues in the aerodigestive tract.  This section 
probed the participant’s dietary history, such as caffeine intake, use of dairy products, or 




    
 
 
recreational drugs.  
 
 
Voice and Swallowing Disorder History 
 Rates of voice and swallowing disorders may be higher among patients with SS as 
compared with the general population (Doig et al., 1971; Roy et al., 2005; Ruiz Allec et 
al., 2011; Sanz et al., 2011).  However, a comprehensive examination of the etiology, 
onset, course, presentation, and treatment of these conditions in patients with SS has yet 
to be undertaken.  This survey examined details of the participant’s current and/or 
previous voice and swallowing concerns with the intention of defining correlates of voice 
and swallowing concerns, patterns of change across the lifespan, typical disease-related 




 Numerous items in the survey rated the severity of specific symptoms, general 
health, and the autoimmune condition.  Along with these items included in the main body 
of the survey, severity appendices were administered specific to the autoimmune 
diagnoses.  Severity scales specific to SS included Sicca Symptoms Inventory-Short 
Form (SSI; Bowman et al., 2003) and European League Against Rheumatism (EULAR) 
Sjögren’s Syndrome Patient Reported Index (ESSPRI; Seror et al., 2011).  The SSI is a 
10-item, psychometrically validated, dryness-specific instrument that is found to 
distinguish patients with SS from other rheumatic diseases.  The ESSPRI is a three-item, 
construct validated instrument designed to measure symptoms of primary SS and is 




    
 
 
potential effects of other comorbid autoimmune conditions in the study population. 
Severity scales for these comorbid autoimmune conditions included the Rheumatoid 
Arthritis Pain Scale (RAPS; Anderson, 2001), the Audit of Diabetes-Dependent Quality 
of Life, version 19 (ADDQOL19; Bradley et al., 1999), the Lupus Quality of Life (Lupus 
QOL; McElhone et al., 2007), and the World Health Organization Disability Assessment 
(Ustun et al., 2010).  These scores were compared with the voice and swallowing severity 
scales to determine relationships among symptoms and comorbid conditions.      
Thus, the survey, as constructed, facilitated understanding of the prevalence of 
voice and swallowing disorders in SS.  Further, it permitted analysis of interactions 
among the above domains, including the delineation of risk factors, prognostic indicators, 
treatment outcomes, and functional implications.  Consistency and accuracy of survey 
instrument administration was ensured using three primary methodologies.  First, all 
research assistants received individual training and instruction on survey administration.  
They were permitted to ask questions and take notes regarding administration and 
response to participant questions.  Second, each research assistant was required to 
practice administering the survey to nonparticipants prior to interviewing participants.  
Third, research assistants were audited periodically via survey instrument data entry and 
through bimonthly research team meetings to ensure accuracy of survey administration.  
Interrater reliability of the accuracy of data entry was calculated on 10% of the surveys 












 Data analysis procedures included those used in other epidemiology studies 
conducted by this group (Roy et al., 2007a, 2007b; Tanner et al., 2011).  Medical, 
familial, environmental, and social history data were examined using contingency tables, 
summary statistics, chi-square tests (χ2), and risk ratios (RRs). In the following section, 
data analysis procedures are described in detail. 
 The prevalence and severity of voice and swallowing problems in the SS 
population were evaluated using descriptive statistics.  Variables were examined using 
contingency tables and multiple logistic regression.  Bivariate analyses of association 
were evaluated for statistical significance using the χ2, the Mantel-Haenszel Chi-square 
(MH χ2), and the Cochran-Mantel-Haenszel Statistic (CMH).  The χ2 is used to test for 
independence between variables, the MH χ2 is used to test for differences in trends 
between variables, and the CMH is used to test for independence after adjusting for 
potential confounding factors.  Tests that beta coefficients in the logistic regression 
models equal zero were based on the Wald test, which follows an approximate χ2 
distribution.   
To analyze risk factors for and impact of voice and swallowing disorders in SS, 
cross-tabulations were used to perform bivariate analyses between selected variables, 
with statistical significance based on the χ2.  The t statistic was used for testing the null 
hypothesis of equality of means between groups (i.e., those with voice and swallowing 
disorders vs. those without), with the t statistic computed using approximate degrees of 
freedom from Satterthwaite’s approximation when the variances between the two groups 




    
 
 
variables) RRs were estimated using logistic regression to establish specific risk factors 
for reporting voice and swallowing disorders.  The association between history of a voice 
or swallowing disorder and presence of selected risk factors (e.g., employment 
classification, work-related voice use issues, history of gastroesophageal reflux disease, 
frequent colds or sinus infections, chemical exposures, and many other disease entities) 
were assessed for homogeneity across the levels of age and sex using the Breslow–Day 
test for homogeneity.  Multiple logistic regression modeling was employed, with 
interaction terms among significant main effects evaluated in the model.   
RRs can range from 0 to infinity. The RR is statistically significantly different 
than 1.0 at the 0.05 level of significance if the 95% CI does not include 1.0.  A RR of less 
than 1 indicates a negative association, a RR of 1 indicates no association, and a RR of 
more than 1 indicates a positive association between two variables. If both the lower and 
upper limits of the CI are less than 1, there is a significant negative association, whereas 
if both the lower and upper limits of the CI are greater than 1, there is a significant 
positive association. RRs may be interpreted literally and describe the extent to which the 
likelihood of possessing a particular risk factor (i.e., a specific health condition) increases 
the presence of a voice disorder. For example, individuals with SS who have a voice 
disorder are 1.5 times as likely to possess the specified health condition versus 
individuals with SS who did not report voice problems.  
Finally, whether the relationship between severity of voice or swallowing 
disorders and selected dichotomous risk factors depends on duration, frequency, sex, and 
age, was addressed by assessing interaction terms among the significant main effects in 




    
 
 
backward stepwise logistic regression, were retained in the model.  This conservative 
value was used to minimize the probability of committing a type I error. Two-sided tests 
of significance were based on the 0.05 level against a null hypothesis of no association.  
Analyses were performed using SAS version 9.1 (SAS Institute Inc., Cary, NC, USA, 
2003).  Procedure statements used in SAS for assessing the data included PROC FREQ, 























Demographic Characteristics, Autoimmune Comorbidities,  
and Voice Disorders 
 Participants with SS ranged in age from 20.5 to 93.4, with mean age 59.4 (SD = 
14.1).  A description of the 101 participants is shown in Table 2.  Most were women, 
non-Hispanic Whites, had a current household yearly gross income of $60,000 or more, 
and had at least some college education.  
Years with SS ranged from 1 to 54 (M = 10.5, SD = 9.9).  The number of 
participants currently taking medication for the syndrome was 76 (75.2%), ranging in 
years from 1 to 53 (M = 9.4, SD = 9.8).  Years with the syndrome was only associated 
with ethnicity (M = 12.4, SD = 11.1 for Hispanics vs. M = 10.3, SD = 9.8 for non-
Hispanics, p = .005).  Use and duration of medication was not significantly associated 
with age, sex, race, ethnicity, income, or education. 
Two severity measures of SS were derived (SSI, with a possible range from 0 
[least severe] to 28 [most severe], and ESSPRI, with a possible range of 0 [least severe] 
to 10 [most severe]).  Participant SSI scores ranged from 0 to 26 (M = 14.3, SD = 5.3) 
and ESSPRI scores ranged from 1 to 9.7 (M = 5.9, SD = 2.0).  Severity scores did not 
significantly differ across the levels of age, sex, race, ethnicity, income, or education.  
Nor did they significantly differ by the years with SS, whether medication was currently  
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Table 2. Description of participants 
  
 n % 
Age   
   20–39 13 12.9 
   40–59 9 8.9 
   60–69 24 23.8 
   70–79 33 32.7 
   80+ 22 21.8 
Sex   
   Men 7 6.9 
   Women 94 93.1 
Ethnicity/Race   
   NH–White 89 88.1 
   NH–Asian 1 1.0 
   NH–Native American/Alaska Native 3 3.0 
   Hispanic 8 7.9 
Household Yearly Gross Income   
   < $20,000 18 19.8 
   $20,000–$39,999 19 20.9 
   $40,000–$59,999 17 18.7 
   $60,000+ 37 40.7 
   Missing 10  
Education   
   < High School 5 5.0 
   High School 16 15.8 
   Some College 36 35.6 
   College Bachelors Degree 26 25.7 
   Graduate Training/Degree 18 17.8 
 
 
being used, or the years of medication use. 
 A new variable was created that is the sum of the frequency of additional 
comorbid autoimmune conditions including Rheumatoid Arthritis (RA), Type 1 Diabetes, 
Wegener’s Granulomatosis, Scleroderma (Scl), Dermatomyositis, Polymyositis, Mixed 
Connective Tissue Disease (MCT), and Systemic Lupus (SLE).  Among participants, 56 
(55.45%) were SS only, and 44 (45.6%) were SS with other comorbid autoimmune 
conditions (SS+).  The most common other combination was SS and RA (26, 25.7%), 
though several other combinations were present in fewer participants (see Table 3).  
Those with SS only compared with SS+ were not significantly more likely to have a 
current voice disorder; that is, RR = 1.12 (95% CI [0.81, 1.57]).  SS only versus SS+ did 
not significantly differ by age, sex, race, ethnicity, education, or whether they live alone.    
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Table 3. Distribution of autoimmune  
conditions in the cohort 
 n % 
SS only 56 55.45 
SS+RA 26 25.74 
SS+SLE 5 4.95 
SS+MCT 4 3.96 
SS+RA+SLE 3 2.97 
SS+Scl+SLE 1 .99 
SS+RA+Scl 1 .99 
SS+RA+MCT 1 .99 
SS+Scl 1 .99 
SS+SLE+MCT 1 .99 
SS+RA+Scl+SLE 1 .99 




However, this variable was significantly associated with yearly gross income and 
religion.  Income was only significantly associated with occurrence of SS versus SS+ in 
the < $20,000 category (n = 6 in SS vs. n = 12 in SS+, p = .02).  Religion was only 
significant in 2 participants of Protestant faith with SS versus 0 with SS+ (p = .037). 
 
 
Prevalence of Voice Disorders 
 The majority of participants (n = 60, 59.4%) classified themselves as having a 
current voice disorder.  The prevalence of current voice disorders did not significantly 
differ across the levels of age, sex, race/ethnicity, income, or education.  In most 
participants their voice disorder tended to begin gradually (88.3% vs. 11.7%) and lasted 
for more than 4 weeks (83.3% vs. 16.7%).  For those with a voice disorder, 4.0% first 
noticed the disorder within the past year, 33.3% 1 to 3 years earlier, 31.4% 4 to 9 years 
earlier, and 31.4% 10 or more years earlier.  The severity of SS was significantly 
associated with having a voice disorder based on mean ESSPRI scores (6.3 [SD = 1.8] vs. 
5.4 [2.1], p = .020) and approached significance based upon mean SSI scores (15.1 [SD = 
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 Levels of selected voice-related symptoms were identified in our participant 
population (Table 4).  Participants were asked to quantify the frequency of selected voice 
symptoms, where “daily” = 1, “weekly” = 2, “monthly” = 3, “several times a year” = 4, 
and “yearly or less” = 5.  The mean frequency of the selected voice symptoms ranged 
from 1.3 to 3.0 (M = 2.4, SD = 0.5).  All but two of the voice-related symptoms were 
significantly associated with the participants who indicated that they had a voice disorder 
(see Table 4).  Regression analysis showed that the SSI severity score was significantly 
associated with chronic throat dryness (Partial r
2
 = 7.3%, p = .006), a monotone voice (r
2
 
= 5.7%, p = .011), and a wobbly or shaky voice (r
2
 = 4.3%, p = .031).  The ESSPRI 
severity score was only simultaneously significantly associated with chronic throat  
 
 
Table 4. Levels of selected voice-related symptoms and  
presence of a current voice disorder 
 Current Frequency* Voice Disorder χ2 
Symptom % M (SD) n % p 
Chronic dryness in your throat 80.2 1.3 (0.8) 54 66.7 .003 
Frequently clear your throat 60.4 1.8 (1.2) 42 68.8 .017 
Hoarseness 51.5 3.0 (1.5) 44 84.6 < .0001 
A loss of singing range 50.5 2.1 (1.2) 39 76.5 .0004 
Voice tires or changes quality after short use 42.6 2.3 (1.3) 37 86.1 < .0001 
Difficulty projecting your voice 41.6 2.3 (1.5) 31 73.8 .013 
An effort to talk 40.6 2.8 (1.5) 35 85.4 < .0001 
Trouble speaking or singing softly 38.6 2.4 (1.4) 35 89.7 < .0001 
Discomfort while using your voice 35.6 2.3 (1.5) 31 86.1 < .0001 
A bitter or acid taste 30.7 2.8 (1.3) 20 64.5 .487 
Chronic soreness in your throat 26.7 2.1 (1.1) 21 77.8 .023 
Wobbly or shaky voice 23.8 2.5 (1.3) 21 87.5 .001 
An “airy” or “breathy” voice 16.8 3.0 (1.2) 15 88.2 .008 
A monotone voice (monopitch) 13.9 2.3 (1.3) 12 92.3 .010 
Wet, gurgley voice quality 6.9 3.0 (1.7) 5 71.4 .502 
*1 = Daily, 2 = Weekly, 3 = Monthly, 4 = Several times per year, 5 = Yearly or less 
Note. Only p values significant at the < .05 level are bolded. 
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soreness (7.1%, p =  .007). 
 
 
Voice Use Patterns, General Health, Lifestyle, and Voice Disorders 
 To assess the impact of participants’ voice use patterns, general health, and 
lifestyle on experiencing a current voice disorder, they were asked questions related to 
each of these areas.  RRs for the significant variables were also determined in order to 
report how much more likely someone who possesses the respective attribute or condition 
is to report a voice disorder versus someone who does not have the attribute or condition.  
Questions regarding voice use patterns were asked to establish the frequency of specific 
vocal behaviors during the day, vocally demanding jobs, and any job-related voice 
disorders.  Participants were asked general health questions to establish the history of 
specific medical conditions and coinciding medication use, history of environmental 
inhalants, bodily tension, and family history of voice and swallowing problems.  Lifestyle 
questions were asked regarding use of tobacco, alcohol, and drugs, as well as exercise 
patterns and personality descriptors.  Table 5 lists each condition addressed, the number 
of participants with each condition who also reported a current voice disorder, the 
resulting significance patterns, and RRs.  The self-reported factors associated with 
significantly elevated RRs, from greatest to least, include bronchitis (RR = 1.88), jaw 
tension (RR = 1.7), abdomen tension (RR = 1.67), current exposure to secondary tobacco 
smoke (RR = 1.64), vocally demanding occupation (RR = 1.60), stomach or duodenal 
ulcer (RR = 1.58), job-related voice disorder (RR = 1.58), often/constant neck/throat 
tension (RR = 1.55), asthma (RR = 1.53), family history of any swallowing problems 







Table 5. Current voice disorder and selected conditions  
 Current Voice Disorder χ2 RR [95% CI] 
Medical Condition n % p  
   Arthritis 35 58.3 .578  
   Heart disease 9 81.8 .187  
   Hypertension 26 57.8 .765  
   Circulatory problems 24 70.6 .169  
   Kidney problems 15 75.0 .113  
   Thyroid problems 29 64.4 .428  
   Stomach or duodenal ulcer 24 80.0 .006 1.58 [1.18, 2.11] 
   Esophageal reflux 40 64.5 .187  
   Stroke 8 66.7 .600  
   Respiratory allergies 23 63.9 .745  
   Pneumonia 39 69.6 .041 1.49 [1.04, 2.13] 
   Emphysema 2 50.0 .696  
   COPD 2 100.0 .483  
   Hearing loss 23 74.2 .044 1.40 [1.04, 1.90] 
   Bronchitis 43 74.1 .002 1.88 [1.26, 2.80] 
   Asthma 18 81.8 .016 1.53 [1.16, 2.05] 
   Severe neck, back, or head injury 22 66.7 .301  
   Chronic pain 43 64.2 .170  
   Cancer 15 68.2 .343  
   Depression or anxiety 37 61.7 .576  
   Sleep disorder 19 73.1 .167  
   Stopped menstrual periods 45 60.8 .280  
Swallowing     
   Current swallowing problem 41 63.1 .313  
   Swallowing problem began with RX reaction 1    
   Swallowing problem began with illness 8 50.0 .159  
   Swallowing problem began after surgery 5 100.0 .076  
   Past swallowing problem 12 52.2 .422  
   Family history of any type of swallowing problem 14 82.4 .035 1.50 [1.12, 2.02] 
Medications for the following conditions     
   Bronchitis 0    
   Asthma 12 75.0 .176  
   Severe neck, back, or head injury 6 75.0 .566  
   Chronic pain 31 68.9 .250  
   Cancer 2 50.0 .383  
   Depression or anxiety 23 60.5 .811  
 
 





Table 5. Continued 
 Current Voice Disorder χ2 RR [95% CI] 
Medical Condition n % p  
   Sleep disorder 10 66.7 .390  
Condition      
   Colds (3+ vs. < 3 year) 45 60.0 .836  
   Sinus infections (3+ vs. < 3 year) 41 56.2 .284  
   Sore throat (3+ vs. < 3 year) 38 54.3 .115  
   Postnasal drip (Chronically vs. less) 23 60.5 .859  
Head and neck surgery 28 60.9 .870  
Breathing assistance 11 73.3 .234  
Ever used tobacco products 15 65.2 .518  
   At any year in your life, drank an average of one or more alcoholic beverages a week. 23 62.2 .622  
Ever used recreational drugs 7 71.4 .502  
Experience tension     
   Neck/Throat (often/constantly vs. otherwise) 35 72.9 .009 1.55 [1.11, 2.16] 
   Jaw  20 87.0 .002   1.70 [1.30, 2.22] 
   Shoulders  29 67.4 .157  
   Abdomen  11 91.7 .016 1.67 [1.29, 2.15] 
Family history of any type of voice problem 7 87.5 .092  
Voice activity     
   Talk (often/constantly vs. otherwise) 47 58.0 .569  
   Talk quietly 30 68.2 .115  
   Whisper 3 50.0 .629  
   Talk loudly 20 55.6 .558  
   Sing 7 53.8 .662  
   Shout, yell or cheer 1 25.0 .153  
   Clear your throat 26 68.4 .152  
   Laugh 35 59.3 .984  
   Cough 15 60.0 .944  
Ever in an occupation requiring you to talk a lot on a daily basis 52 64.2 .048 1.60 [0.92, 2.81] 
Experience voice disorders with this job 28 77.8 .023 1.58 [1.17, 2.14] 
Exposures     
   Excess dust – current 7 41.2 .093  
   Excess dust – past 31 70.4 .047 1.38 [1.01, 1.90] 
   Fumes from cleaning products – current 16 55.2 .582  
   Fumes from cleaning products – past 28 69.9 .784  
   Secondary tobacco smoke – current 10 90.9 .024 1.64 [1.26, 2.13] 
 
 





Table 5. Continued 
 Current Voice Disorder χ2 RR [95% CI] 
Medical Condition n % p  
   Secondary tobacco smoke – past 39 65.0 .166  
   Dry air – current 53 62.4 .165  
   Dry air – past 55 63.2 .052  
Exercise (yes vs. no) 54 60.0 .728  
Personal Description     
   Quiet vs. talkative 23 57.5 .803  
   Easy-going vs. worrier 30 55.6 .398  
   Active vs. inactive 46 56.1 .160  
   Happy vs. sad 54 58.7 .642  






excess dust (RR = 1.38).   
 
 
Voice Disorders and Quality of Life 
 To assess the functional impact of a voice disorder on the SS population, several 
quality of life measures were included in the survey.  These measures were associated 
with current voice disorders, current voice symptoms, and SS severity.  The VRQOL, a 
measure of the impact of having a voice disorder on quality of life, ranged from 17 
(poorest quality of life) to 100 (best quality of life), with mean 83.2 (SD = 18.3).  
VRQOL was not significantly associated with age, sex, race, ethnicity, income, or 
education, but was significantly related to whether the participant indicated having a 
voice disorder (75.7 [SD = 19.7] vs. 94.2 [SD = 7.8], p < .0001).  Mean VRQOL was 
significantly lower for all of the selected voice-related symptoms except the same 2 items 
identified in Table 4 (see Table 6).  Regression analysis showed that the VRQOL 
measure was significantly associated with the SSI severity score (Partial r
2
 = 6.9%, p = 
.008) and the ESSPRI severity score (7.2%, p = .007).   
To assess the relationship between daily, overall health and the potential effects 
on the voice, SS severity, and quality of life, an additional single-question measure was 
used.  This variable about “how you feel, overall, on a daily basis” was significantly 
associated with chronic throat soreness and frequent throat clearing.  Of those with 
excellent/good health, 19.7% had chronic throat soreness compared with 37.5% for those 
with fair/poor health (χ2 p = .048).  Of those with excellent/good health, 50.8% had 
frequent throat clearing compared with 75.0% for those with fair/poor health (χ2 p = 
.015).  Along with specific voice symptoms, “how you feel...” was compared with 
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Table 6. Voice symptoms and relation with VRQOL scores 
 VRQOL Score 
Symptom No Current Symptom  Current Symptom   
 M (SD) M (SD) t statistic  
p value 
Chronic dryness in your throat 91.4 (11.9) 81.2 (19.1) .004 
Frequently clear your throat 89.3 (13.8) 79.2 (19.9) .003 
Hoarseness 89.3 (13.8) 77.4 (20.2) .001 
A loss of singing range 89.5 (15.0) 77.0 (19.2) .0004 
Voice tires or changes quality after short use 89.3 (15.6) 74.9 (18.7) < .0001 
Difficulty projecting your voice 91.0 (11.3) 72.3 (20.7) < .0001 
An effort to talk 92.2 (9.1) 70.0 (20.5) < .0001 
Trouble speaking or singing softly 90.2 (11.5) 72.1 (21.5) < .0001 
Discomfort while using your voice 90.1 (12.4) 70.7 (20.8) < .0001 
A bitter or acid taste 84.1 (17.7) 81.2 (19.8) .462 
Chronic soreness in your throat 87.4 (14.4) 71.5 (22.8) .002 
Wobbly or shaky voice 88.6 (12.7) 65.9 (22.7) < .0001 
An “airy” or “breathy” voice 85.9 (16.4) 69.9 (22.0) .001 
A monotone voice (monopitch) 85.8 (16.3) 65.5 (22.3) .0001 
Wet, gurgley voice quality 83.1 (18.8) 83.7 (10.9) .938 
Note. Only p values significant at the < .05 level are bolded.  
 
 
reporting a voice disorder, VRQOL, SSI, and ESSPRI.  As reported in Table 7, 
reductions in reported overall health were significantly associated with the presence of a 
voice disorder, as well as reductions in voice-related quality life, and worsening disease 
severity.  
 The general quality of life measure, SF-36, and its subscales were compared with 
VRQOL, current voice disorder, and current voice symptoms.  The two summary 
measures of the SF-36 are physical health and mental health.  Each summary measure is 
associated with four subscales (physical health: physical function, role-physical, bodily 
pain, general health; mental health: vitality, social functioning, role-emotional, mental 
health).  The raw scores from the survey are coded into a 0 to 100 scale, with 100 
representing the highest state of health.  Average scores for each of the scale items across 
all participants have been reported previously, ranging from the 70s for general health, 
bodily pain, and energy/fatigue, to the 80s for social functioning, physical functioning, 
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Table 7. “How you feel on a daily basis” and relation with presence  
of a current voice disorder, as well as VRQOL,  
SSI, and ESSPRI scores 
  Voice Disorder VRQOL SSI ESSPRI 
 






M (SD) M (SD) M (SD) 
Excellent 10 3.4 19.5 93.5 (7.6) 11.0 (3.3) 2.9 (1.1) 
Good 51 53.3 46.3 85.4 (18.9) 13.6 (5.5) 5.5 (1.5) 
Fair 33 33.3 31.7 80.7 (16.4) 15.4 (5.0) 7.0 (1.6) 
Poor 7 10.0 2.5 64.4 (20.5) 18.0 (4.4) 8.2 (1.2) 
   χ2 p = .034 F p = .007 F p = .019 F p < .0001 
 
 
role limitations – physical health, and emotional well-being, and to the 90s for role 
limitations – emotional stresses.  The highest possible score for physical functioning is 
obtained by performing all types of physical activity including the most vigorous without 
limitations due to health; for role-physical is obtained by having no problems with work 
or other daily activities; for bodily pain is obtained by having no pain or limitations due 
to pain; for general health is obtained by evaluating personal health as excellent; for 
energy/fatigue is obtained by feeling full of pep and energy all the time; for social 
functioning is obtained by performing normal social activities without interference due to 
physical or emotional problems; for role – emotional is obtained by having no problems 
with work or other daily activities; and for mental health is obtained by feeling peaceful, 
happy, and calm all of the time.  Both SF-36 summary measures and six of its eight 
subscales were significantly correlated with the VRQOL (see Table 8).  This association 
seems to disproportionately contribute to reductions in the mental health, rather than the 
physical health, summary measure.  Table 9 identifies the extent that selected voice 
symptoms influenced specific quality of life domains as assessed by the SF-36.  Specific 
voice symptoms were statistically correlated with subscales, namely frequent throat  
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Table 8. Mean SF-36 subscales and correlations with VRQOL scores 






PHYSICAL Health 49.9 23.8 .23 .018 
Physical Functioning 60.3 29.6 .18 .066 
Role-Physical 50.0 43.3 .14 .167 
Bodily Pain 53.6 25.4 .26 .009 
General Health  37.4 21.0 .29 .003 
     
MENTAL Health 66.9 18.4 .35 .0003 
Vitality 43.8 23.8 .25 .012 
Social Functioning 70.2 30.5 .35 .0004 
Role-Emotional 81.8 31.1 .27 .006 
Mental Health 75.0 16.7 .24 .014 
     Note. Only p values significant at the < .05 level are bolded. 
 
 
clearing, chronic throat soreness, and difficulty projecting voice.  These symptoms 
seemed to disproportionately contribute to reductions in the physical health summary 
measure aspect of quality of life.  For the model with summary physical health as the 
dependent variable, only frequent throat clearing was significant (slope = -16.2, SE = 4.6, 
p = .001). For the model with summary mental health as the dependent variable, only 
discomfort while using voice was significant (slope = -13.7, SE = 3.6, p = .0002).  
Reporting a voice disorder was not significantly associated with any of the eight 
subscales or the physical or mental health summary measures.   
 Of the 60 participants who reported a current voice disorder, only 16 (15.8%) had 
ever sought professional help to improve their voice.  Of the 16, six saw a singing or 
acting teacher or coach, five saw a physician, three saw a speech-language pathologist, 
and two saw both a physician and speech-language pathologist.  Almost all indicated that 
it helped their voice (13/16 = 81.2%).  Seeking professional help to improve their voice 













Table 9. Mean SF-36 subscale scores according to current voice symptoms 
 
  PF  RP  BP  GH  VT  SF  RE  MH  
 n Slope SE M SD M SD M SD M SD M SD M SD M SD 
Hoarseness 52                 
Voice tires 43                 
Trouble speaking 39                 
Difficulty projecting 42     -10.2 5.0           
Loss of singing range 51                 
Discomfort 36   -18.3 8.9       -17.3 6.1 -22.2 6.1 -12.6 3.3 
Monotone 13                 
Effort 41                 
Chronic dryness 81                  
Gurgley voice  7                 
Chronic soreness 27     -12.7 5.5 -9.7 4.6 -13.5 5.2       
Frequent throat clear 61 -19.9 5.7     -10.9 4.1         
Bitter or acid taste 31                 
Wobbly/shaky 24                 
Airy/breathy 17                 
Note. Only significant slope estimates appear in the table, p < .05. 
Physical Health: Physical Function (PF), Role-Physical (RP), Bodily Pain (BP), General Health (GH) 






    
Discussion 
 Epidemiologic studies of voice disorders in SS are relatively rare and report 
varying results.  The current investigation reports findings from the largest epidemiology 
study of voice disorders undertaken in SS.  Important results are discussed below. 
The majority (59%) of participants with SS reported a current voice disorder.  
Most of these voice disorders began gradually (88%), were chronic, lasting more than 
four weeks (83%), and in many cases were longstanding (i.e., 63% persisted 4+ years).  
The likelihood of reporting a current voice disorder was associated with increasing 
disease severity of SS, but interestingly was not associated with the age or sex of the 
participants.  Furthermore, additional comorbid autoimmune conditions did not appear to 
increase the likelihood of reporting voice disorders.  These results confirm that chronic, 
longstanding voice disorders are common in SS and appear to be related to worsening 
disease severity.  Differences in prevalence rates were not observed between primary SS, 
secondary SS, or when the disease coexisted with other autoimmune conditions.  
Patients with SS reported numerous voice symptoms, which often occurred on a 
daily and/or weekly basis. With the exception of bitter/acid taste and a wet/gurgley voice 
quality, all of the voice symptoms were significantly associated with reporting a current 
voice disorder.  Four symptoms were reported by more than half of all participants: 
chronic throat dryness (80%), frequent throat clearing (60%), hoarseness (52%), and loss 
of singing range (51%).  Furthermore, it appears that certain voice symptoms, such as 
chronic throat dryness and chronic throat soreness, are particularly meaningful for 
individuals with SS and accounted for a significant amount of variance in overall SS 
severity scores. This suggests that symptoms especially involving physical sensations 
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within the laryngopharyngeal region have particular salience for individuals with SS. 
 This study also examined associated medical conditions and risk factors that 
potentially contributed to voice disorder reporting.  Certain medical conditions and 
lifestyle or occupational factors increased vulnerability for experiencing a voice disorder.  
Based upon inspection of the RR data, several interesting factors emerged.  Vocally 
demanding occupations and job-related voice disorders were among the significant risk 
factors.  This association seems obvious since extensive vocal use may logically 
contribute to voice disorders.  Other risk factors were associated with inhaled irritants, 
such as current exposure to secondary tobacco smoke and past exposure to excess dust.  
These inhalants expose the laryngeal structures to potential damage and, therefore, may 
contribute to structural or compensatory voice problems.  Several of the risk factors 
which are associated with decreased breathing efficiency—bronchitis, asthma, and 
pneumonia—may impact the respiratory pressure required for adequate voicing and may 
in turn effect ability for efficient voicing.  Several other risk factors statistically 
associated with reporting a voice disorder included jaw tension, neck/throat tension, and 
hearing loss.  These risk factors seem to have anatomical and/or acoustic connections to 
the voice.  Tension in areas in close proximity to laryngeal structures may contribute to, 
or be a result of, a current voice disorder.  Additionally, hearing loss may effect one’s 
perception and judgment of his or her own voice quality and abilities.  
 
 
Effects of Voice Symptoms and Disorders on Quality of Life in SS 
Our cohort reported high rates of undesirable voice symptoms and related voice 
disorders, and this high frequency of voice-related problems may help to explain some of 
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the untoward effects on quality of life reported by the participants.  Inspection of the 
VRQOL results revealed that voice disorders associated with SS produced mild to 
moderate reductions in voice-related quality of life.  A mean VRQOL score of 83 for our 
group was substantially lower than both the highest possible score of 100 and the non-
voice patient population average score of 98 (Hogikyan & Sethuraman, 1999).  However, 
this mean score is in the mild to moderate range of voice-related handicap.  Lower 
VRQOL scores were associated with increasing severity of SS.  Our finding that severity 
of SS was not correlated with years with SS, but was correlated with lower VRQOL, is 
important.  This indicates that a person with SS can experience lower voice-related 
quality of life at any time point along their disease process.   
The SF-36 general health quality of life measure also revealed important findings.  
Participants in the current study reported a lower overall quality of life than the normative 
data, whether or not they had a voice disorder.  Comparisons between the SF-36 physical 
health and mental health summary measures and the VRQOL were statistically 
significant (p = .018 and p = .0003, respectively).  Additionally, those who reported a 
voice disorder also had poorer quality of life scores on all subscales of the SF-36 versus 
those who did not report a voice disorder.  Although statistical significance was not found 
on the SF-36 subscales for those who reported a voice disorder, some voice symptoms 
were statistically significant: difficulty projecting voice, discomfort while using voice, 
chronic throat soreness, and frequent throat clearing.  Additionally, the voice symptoms 
independently associated with reduced SF-36 physical and mental health subscales were 
frequent throat clearing and discomfort while using voice, respectively.  Interestingly, the 
symptom that seems most obviously related to SS, chronic dryness, was not significantly 
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associated with subscales or summary measures of the SF-36.  Dryness was correlated 
with the SSI, but this is unsurprising given that questions on the SSI specifically address 
the nature and severity of these symptoms.  This discrepancy of the correlations between 
SF-36 and symptoms versus disorders seems to suggest that specific symptoms could be 
disproportionately contributing to reduced overall quality of life.  Specifically, the 
symptoms of discomfort and chronic soreness are linked to more quality of life 
parameters on the SF-36.  Similar to other studies in non-SS populations (Merrill et al., 
2011; Merrill, Roy, & Lowe, 2013), symptoms associated with effort, discomfort, and 
chronic sensations in the throat seem to decrease quality of life.  The negative impact of 
voice disorders on physical and emotional functioning seen in the current study also 
reflects similar observations made by Baylor, Burns, Eadie, Britton, and Yorkston (2011), 
who reported negative effects of communication disorders in a variety of non-SS 
populations, although studies by their group utilized instruments other than the SF-36 
(Baylor et al., 2011; Baylor et al., 2013; Baylor, Yorkston, Eadie, Miller, & Amtmann, 
2009).       
An additional quality of life survey question, “how do you feel, overall, on a daily 
basis,” was significantly correlated with reporting a voice disorder, VRQOL, and SS 
severity.  Similar to the VRQOL and the SF-36, this question was significantly associated 
with specific voice symptoms, including chronic throat soreness and frequent throat 
clearing.   
The one symptom that was significantly associated with all three quality of life 
measures was frequent throat clearing.  It has been reported that chronic throat clearing is 
associated with voice disorders and may be a reaction to triggers such as the perception 
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of dysphonia, foreign body sensation, and increased viscosity of mucous (Bonilha, 
Gerlach, Sutton, Dawson, & Nietert, 2012; Cobeta, Pacheco, & Mora, 2013).  Chronic 
throat dryness may manifest in thicker laryngeal secretions, and it may be the increased 
viscosity of mucous associated with SS that might instigate this frequent symptom in our 
participants.   
Although 59% of participants reported a voice disorder, only 16% sought 
professional help to improve their voices. Importantly, 87% of those who received 
treatment indicated that their voices improved. This finding is particularly interesting 
given that both SS disease severity and (expectedly) VRQOL scores were worse in those 
who reported a voice disorder. Also interesting is the fact that help-seeking behavior was 
not significantly associated with age, sex, race, ethnicity, income, or education.  One 
possible explanation for this low rate of seeking treatment may be limited patient 
education regarding treatment options for voice disorders.  It is important to note that, 
while the reported severity of voice disorders in this group was generally mild, the SS 
severity was moderate. Additionally, SS severity predicted the presence of voice 
disorders. Therefore it is possible that the overall SS severity and associated symptoms 
eclipsed the voice symptoms, perhaps evidenced in their treatment-seeking behaviors. 
Regardless of the potential causes of these treatment-seeking behaviors, the results from 
this study have important implications for symptom identification and referral practices 
in this population.  
Further research surrounding voice disorders in SS is warranted based on these 
quality of life findings.  Having a voice disorder statistically impacted VRQOL and “how 
you feel on a daily basis.”  VRQOL and “how you feel…” were also correlated with the 
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SF-36.  Multiple voice symptoms were statistically associated with all three measures.  
These associations demonstrate the negative impact SS and related voice disorders have 
upon those with this autoimmune condition.  Additional research in this area to further 
analyze the correlations between voice disorders, symptoms, and quality of life may 
demonstrate significance between voice disorders and the SF-36.  Perhaps more 
importantly, future research should investigate novel treatment options for voice 
disorders in this population. 
 
 
Comparisons with the Extant Literature 
Direct comparison of our results from the current study with the studies of SS 
described and critiqued in Table 1 is difficult due to differences in sample sizes, patient 
populations (i.e, numbers of primary SS in the rheumatic groups studied), methodologies, 
and definitions used to determine the presence of a voice disorder.  Therefore, only 
general comparisons can be made.  Our prevalence rate for voice disorders in SS (59%) is 
clearly at odds with absence of significant voice problems reported by Sanz et al. (2011) 
and the 42% reported by Ruiz Allec et al. (2011).  It is important to keep in mind, 
however, that the study by Ruiz Allec et al. (2011) included only 31 SS participants, four 
of whom had primary SS.  The study by Sanz et al. (2011) included only four total SS 
participants of their rheumatic diseases cohort.  Methodologies in both studies were 
distinct in that they defined voice disorders differently.  Similar to findings in the current 
study, Heller et al. (2014) found that dysphonia in SS typically ranges from mild to 
moderate.  This report was based on objective and quality of life measures.  Other studies 
focused on voice symptoms, and hoarseness seemed to be the symptom highlighted most 
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frequently, with a prevalence rate of 19–71% (Doig et al., 1971; Haga et al., 1997).  
Reports of hoarseness from the current study fall in between that range at 52%; however, 
among the 14 other symptoms analyzed in the current study, two other symptoms were 
more prevalent: chronic throat dryness (80%) and frequent throat clearing (60%).  It is 
important to note that the SS diagnostic criteria used by Doig et al. (1971) differs greatly 
from that used in the current study, which followed more recent guidelines.  In a recent 
study, Tanner et al. (2013) reported number of years with SS was associated with voice 
symptoms: vocal effort and throat dryness.  The current study did not reveal any 
associations with years with SS, but with SS severity.  However, the Tanner et al. (2013) 
study focused on hydration voice treatment, rather than epidemiology.  Some studies 
reported a large difference between voice symptoms and signs of voice dysfunction 
observed during instrumentation procedures.  Freeman et al. (2005) reported the 
difference between symptoms and observations was 60–70% versus 20%.  In that study, 
however, only two symptoms were analyzed versus the 15 analyzed in the current study.  
Ruiz Allec et al. (2011) found opposite results in that the prevalence of observed voice 
problems was greater than reported problems (90% vs. 42% in pSS and sSS).  Though the 
current study did not use similar objective measures, we did find a higher rate of both 
voice symptoms and disorders than either of these studies.  Importantly, according to 
Sanz et al. (2011), there seems to be an 81% worsening of voice disorders during 
rheumatic flares.  It is also important to keep in mind that symptoms of a disorder may 
impact quality of life more than signs of dysfunction observed objectively.  When 
comparing risk factors presented in the extant literature, reflux seemed to be the one 
highlighted in other studies (Ogut et al., 2005; Ruiz Allec et al., 2011).  These reports 
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differ from that in the current study, which did not find reflux to be a significant risk 
factor.  The final comparison to be made is in the area of quality of life differences 
resulting from voice disorders in SS.  Sanz et al. (2011) was the only study in Table 1 to 
address socioemotional effects of these disorders.  They reported that voice disorders 
negatively impact physical and daily living parameters and reduce quality of life.  This is 
similar to findings in the current study; however, the Sanz et al. (2011) study did not find 
statistical significance for voice disorders in SS, likely due to the small number of SS 
participants in that study.      
Comparisons between the current study and several non-SS studies were made to 
review interesting risk factors in the current study that were not independently associated 
with reporting a current voice disorder.  These factors include frequent colds and sinus 
infections and reflux, which have previously been associated with reporting a voice 
disorder in non-SS populations (Merrill, Anderson, & Sloan, 2011; Roy et al., 2005).  
Increased age has also been associated with increased prevalence of voice disorders in a 
non-SS population compared with the general population (29% in age 65+ vs. 6.6%, 
respectively; Roy et al., 2005; Roy et al., 2007a).  Although the current study included an 
uneven distribution of participants across each age stratum, the majority of participants 
(78%) were age 60 or older.  The geriatric population was well represented in this study, 
and statistical analyses did not find a correlation between increased age and increased 
prevalence of voice disorders.  This, again, seems to show that SS severity is the true risk 
factor for reporting a voice disorder, irrespective of age.  The finding that comorbid 
autoimmune conditions did not seem to be associated with voice problems is also 
intriguing.  In a concurrent study (Wright, 2014), RA was found to have a higher 
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incidence of voice disorders than the general population (35% vs. 6.6%), but not as high 
as the incidence found in SS or SS with RA in the current study.  This, again, seems to 
imply that SS alone may represent the greatest risk factor for voice disorders and that 

























Prevalence of Swallowing Disorders 
 The majority of participants (n = 65, 64.4%) classified themselves as having a 
current swallowing disorder wherein they experienced difficulty moving food or liquid 
from their mouth to their stomach or anytime they experienced choking or frequent throat 
clearing during or following mealtime.  In most participants (n = 55, 84.6%) their 
swallowing disorder began gradually and lasted for more than 4 weeks (n = 59, 90.8%).  
For those with a swallowing disorder, 15% first noticed the disorder within the past year, 
18.3% 1–3 years earlier, 30% 4–9 years earlier, and 36.7% 10 or more years earlier.  The 
prevalence of a current swallowing disorder did not significantly differ across the levels 
of age, race/ethnicity, income, or education.  However, significant difference was found 
for sex, in that male participants were more likely to report a swallowing disorder (100% 
of males vs. 61.7% of females, p = .041).  Having SS+MCT was significantly associated 
with reporting a current swallowing disorder (χ2, p = .041).  Other comorbid autoimmune 
conditions showed no significant correlation.  SS severity was significantly associated 
with having a swallowing disorder based on mean SSI scores (15.8 [SD = 5.2] vs. 11.5 
[SD = 4.2], p < .0001), approximated significance based upon mean ESSPRI scores (6.2 
[SD = 1.9] vs. 5.5 [SD = 2], p = .085), but was not significantly associated 
with the overall disease severity question (p = .111).  Length of time with SS was not 
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 Levels of selected swallowing-related symptoms were identified in our patient 
population (Table 10).  Nearly all of the 101 participants reported at least one swallowing 
symptom (n = 99, 98%).  Of the 19 swallowing symptoms, five were reported by more 
than 50% of participants: dry mouth (96%), difficulty swallowing solids (64%), food 
sticking in the throat (61%), need for excessive chewing (55%), and taking smaller bites 
in order to swallow safely (55%).  According to CMH statistical analyses, 13 of the 19 
swallowing symptoms were significantly associated with the participants who indicated 
they had a swallowing disorder (see Table 10).  RRs reported in Table 10 reveal how 
much more likely someone is to report a swallowing disorder if they also have a specific 
symptom.  The swallowing symptoms associated with significantly elevated RRs, from 
greatest to least, included food sticking in throat (RR = 3.1), difficulty swallowing solids 
(RR = 3.0), take smaller bites of food (RR = 2.4), take a longer time to eat (RR = 2,3), 
pain/pressure in the throat/chest while swallowing (RR = 2.3), need for excessive 
chewing (RR = 2.2), coughing/throat clearing/choking while eating (RR = 1.8), forcibly 
regurgitate stuck foods (RR = 1.8), avoid eating certain foods (RR = 1.8), difficulty 
swallowing liquids (RR = 1.7), inability to control liquid/food/saliva in the mouth (RR = 
1.5), increased mucous/phlegm while eating (RR = 1.5), and difficulty swallowing 
medication (RR = 1.3).  The length of time of having SS was significantly associated 
with only one swallowing symptom: sneezing while eating; those with this symptom had 









Table 10. Levels of selected swallowing-related symptoms and presence of a current swallowing disorder 
 Current Frequency* Swallow Problem χ2 RR [95% CI] 
Symptom % Most reported n (%) p Value  
Take longer time to eat because of swallowing problem (n = 48) 47.5 1 44 (91.67) < .0001 2.3 [1.6, 3.3] 
Difficulty swallowing liquids (n = 21) 20.8 2 20 (95.24) .001 1.7 [1.4, 2.1] 
Difficulty swallowing solids (n = 65) 64.4 1 55 (84.62) < .0001 3.0 [1.8. 5.2] 
Difficulty swallowing medications (n = 47) 46.5 1 35 (74.47) .049 1.3 [1.0, 1.8] 
Gurgley or wet voice during or after eating (n = 5) 5.0 2–3 4 (80) .456  
Coughing, throat clearing, or choking before, during or after eating (n = 
46) 
45.5 1 39 (84.78) < .0001 1.8 [1.3, 2.4] 
Inability to control food, liquid, or saliva in the mouth (n = 28) 27.7 1 24 (85.71) .006 1.5 [1.2, 2] 
Sneezing during or after a meal (n = 12) 11.9 2 9 (75) .415  
Pain or pressure in the throat or chest during swallowing (n = 40) 39.6 2 39 (97.5) < .0001 2.3 [1.7, 3.1] 
Wheezing after eating (n = 6) 5.9 1 6 (100) .061  
Food comes out of the nose while eating (n = 3) 3.0 4 3 (100) .193  
Need to chew excessively in order to swallow safely (n = 55) 54.5 1 47 (85.45) < .0001 2.2 [1.5, 3.2] 
Dry mouth (n = 97) 96.0 1 63 (64.95) .543  
Difficulty placing food in mouth (n = 3) 3.0 2 3 (100) .193  
Sensation of food sticking in throat (n = 62) 61.4 2 54 (87.1) < .0001 3.1 [1.9, 5.1] 
Forcibly regurgitate food stuck in throat (n = 18) 17.8 3 18 (100) .001 1.8 [1.5, 2.1] 
Avoid eating certain foods because of swallowing disorder (n = 41) 40.6 1 36 (87.8) < .0001 1.8 [1.4, 2.4] 
Increased mucous or phlegm in throat before, during, or after eating (n = 
30) 
29.7 1 25 (83.33) .010 1.5 [1.4, 1.9] 
Take smaller bites of food to swallow safely (n = 55) 54.5 1 48 (87.27) < .0001 2.4 [1.6, 3.5] 
       *1 = Daily, 2 = Weekly, 3 = Monthly, 4 = Several times a year, 5 = Yearly or less 





     
Regression analysis showed that the SSI severity score was simultaneously 
significantly associated with taking smaller bites (partial r
2
 = .161, p < .0001), 
mucous/phlegm while eating (partial r
2
 = .068, p = .004), and difficulty placing food in 
the mouth (partial r
2
 = .050, p = .011).  The ESSPRI severity score was simultaneously 
significantly associated with mucous/phlegm while eating (partial r
2
 = .088, p = .003) and 
wheezing while eating (partial r
2
 = .056, p = .013).  The overall disease severity question 
was only significantly associated with one symptom: taking a longer time to eat.  Of 
those with no problem, 33.3% took a longer time to eat compared with 70.8% for those 
with a severe problem (MH χ2 p = .010).  Participants were asked to quantify the 
frequency of selected swallowing symptoms, where “daily” = 1, “weekly” = 2, “monthly” 
= 3, “several times a year” = 4, and “yearly or less” = 5 (Table 10).  The majority of the 
selected swallowing symptoms occurred daily in most participants (11 of 19 [57.9%] 
daily, 6 [31.6%] weekly, 2 [10.5%] monthly, 1 [5.3%] several times a year).  Increased 
frequency of one symptom was significantly associated with length of time of having SS: 
pain in the throat/chest while swallowing (p = .044).  SSI severity scores were 
significantly associated with increased frequency of difficulty swallowing solids (p = 
.011) and taking smaller bites in order to swallow safely (p = .004).  ESSPRI severity 
scores were significantly associated with increased frequency of coughing while eating (p 
= .031).  The question regarding overall disease severity was significantly associated with 
increased frequency of food getting stuck in the throat (p = .004) and taking smaller bites 






    
 
 
Voice Use Patterns, General Health, Lifestyle,  
and Swallowing Disorders/Symptoms 
 The potential influence of possible risk factors including participants’ voice use 
patterns, general health, and lifestyle on reporting a current swallowing disorder was 
examined.  RRs for the significant variables were also determined in order to report how 
much more likely someone who possesses a particular attribute/condition is to report a 
swallowing disorder, versus someone who does not have the attribute/condition.  
Questions regarding voice use patterns were considered for analyses to determine 
whether these voice patterns impacted swallowing.  Table 11 lists each condition 
addressed, the number of participants with each condition who also reported a current 
swallowing disorder, the resulting correlations, RRs, and CIs.  The self-reported factors 
associated with significantly elevated RRs, from greatest to least, include voice problem 
longer than 4 weeks (RR = 2.0), esophageal reflux (RR = 1.92), current exposure to 
secondary tobacco smoke (RR = 1.67), often/constant neck/throat tension (RR = 1.66), 
frequent throat clearing (RR = 1.42), chronic postnasal drip (RR = 1.4), and stomach or 
duodenal ulcer (RR = 1.38).     
 Age, race/ethnicity, income, and education were not significantly associated with 
swallowing symptoms.  Stepwise regression showed that swallowing symptoms were 
significantly associated with many risk factors, and polytomous logistic and stepwise 
regression showed symptom frequencies were also significantly associated.  In the end, 
60 (51%) of the 118 risk factors analyzed, along with the mentioned demographic 
questions, were significantly associated with symptoms and increased frequency of 
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Table 11. Current swallowing disorder and selected conditions 
 Current Swallowing 
Disorder 
χ2 RR [95% CI] 
Medical Condition n % p Value  
   Arthritis 38 63.33 .795  
   Rheumatoid arthritis 20 58.82 .408  
   Heart disease 9 81.82 .200  
   Hypertension 29 64.44 .987  
   Circulatory problems 25 73.53 .170  
   Kidney problems 15 75 .267  
   Thyroid problems 30 66.67 .664  
   Stomach or duodenal ulcer 24 80 .033 1.38 [1.06, 1.81] 
   Esophageal reflux 49 79.03 .0001 1.93 [1.29, 2.87] 
   Stroke 10 83.33 .144  
   Respiratory allergies 25 69.44 .427  
   Pneumonia 40 71.43 .097  
   Emphysema 3 75 .650  
   COPD 1 50 .669  
   Hearing loss 23 74.19 .170  
   Bronchitis 38 65.52 .777  
   Asthma 15 68.18 .672  
   Severe neck, back, or head injury 19 57.58 .322  
   Chronic pain 44 65.67 .699  
   Cancer 15 68.18 .672  
   Depression or anxiety 43 71.67 .064  
   Sleep disorder 20 76.92 .121  
   Stopped menstrual periods 43 58.11 .132  
Voice     
   Current voice problem 41 68.33 .313  
   Did the problem begin suddenly? 5 71.43 .851  
   Did the problem last more than 4 weeks? 38 76 .004 2.00 [1.18, 3.38] 
   Past voice problem 19 73.08 .281  
   Family history of any type of voice problem 5 62.5 .910  
Medications for the following conditions     
   Bronchitis 12 75 .262  
   Asthma 32 71.11 .180  
   Severe neck, back, or head injury 3 75 .746  
   Chronic pain 26 68.42 .463  
   Cancer 10 66.67 .147  
 
 













Medical Condition n % p Value  
   Depression or anxiety 12 75 .262  
   Sleep disorder 32 71.11 .180  
Condition      
   Colds (3+ vs. < 3 year) 48 64 .899  
   Sinus infections (3+ vs. < 3 year) 47 64.38 .993  
   Sore throat (3+ vs. < 3 year) 42 60 .170  
   Postnasal drip (Chronically vs. less) 28 53.85 .023 1.40 [1.04, 1.89] 
Head and neck surgery 32 69.57 .318  
Breathing assistance 11 73.33 .432  
Ever used tobacco products 15 65.22 .922  
At any year in your life, drank an average of one or more alcoholic beverages a week 22 59.46 .435  
Ever used recreational drugs 5 71.43 .686  
Experience tension     
   Neck/Throat (often/constantly vs. otherwise) 26 49.06 .001 1.66 [1.22, 2.25] 
   Jaw  46 59.74 .083  
   Shoulders  35 60.34 .328  
   Abdomen  56 62.92 .412  
Family history of any type of swallowing problem 12 70.59 .556  
Voice activity     
   Talk (often/constantly vs. otherwise) 13 65 .947  
   Talk quietly 37 64.91 .894  
   Whisper 60 63.16 .317  
   Talk loudly 40 61.54 .427  
   Sing 56 63.64 .694  
   Shout, yell or cheer 61 62.89 .129  
   Clear your throat 35 55.56 .017 1.42 [1.08, 1.87] 
   Laugh 27 64.29 .99  
   Cough 45 59.21 .060  
Ever in an occupation requiring you to talk a lot on a daily basis 52 64.20 .947  
Experience voice disorders with this job 25 69.44 .378  
Exposures     
   Excess dust – current 9 52.94 .281  
   Excess dust – past 31 70.45 .261  
   Fumes from cleaning products – current 19 65.52 .877  
 
 













Medical Condition n % p Value  
   Fumes from cleaning products – past 31 67.39 .560  
   Secondary tobacco smoke – current 11 100 .009 1.67 [1.41, 1.97] 
   Secondary tobacco smoke – past 42 70 .152  
   Dry air – current 54 63.53 .689  
   Dry air – past 56 64.37 .995  
Exercise (yes vs. no) 56 62.22 .200  
Description     
   Quiet vs. talkative 25 62.5 .752  
   Easy-going vs. worrier 35 64.81 .918  
   Active vs. inactive 53 64.63 .904  
   Happy vs. sad 58 63.04 .378  
 Note. Only the RRs significant at the < .05 level are reported. 





     
swallowing symptoms or frequency of symptoms, along with how many symptoms with 
which they were associated, were esophageal reflux (7), frequent coughing (5), stomach 
or duodenal ulcer (4), frequent sinus infections (4), current choral singing (4), being male 
(4), kidney problems (3), bronchitis (3), chronic pain (3), sleep disorder (3), abdomen 
tension (3), past church singing (3), past volunteer activities (3), acidic foods (3), and past 
exposure to secondary tobacco smoke (3).  Other risk factors were significantly 
associated with one or two symptoms or symptom frequency.  Four of the 19 swallowing 
symptoms were not found to have associated risk factors: wet/gurgley voice while eating, 
sneezing while eating, dry mouth, and avoiding certain foods.   
 
 
Swallowing Disorders and Quality of Life 
 To assess the functional impact of a swallowing disorder on the SS population, 
several quality of life measures were included in the survey and used in analyses.  These 
measures were associated with current swallowing disorders, current swallowing 
symptoms, and SS severity. 
 Scores on the MDADI, a measure of swallowing-related quality of life, can range 
from 0 (poorest quality of life) to 100 (best quality of life).  Participants’ scores ranged 
from 30 to 100, and scores were significantly lower for those who indicated they had a 
current swallowing disorder (M = 75.9, SD = 15.4 vs. 90.1, SD = 11.5, p < .0001).  
MDADI was not significantly associated with age, sex, race, ethnicity, income, or 
education.  Mean MDADI score was significantly lower for 15 of the 19 selected 
swallowing-related symptoms (see Table 12).  Regression analysis showed that the 
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Table 12. Swallowing symptoms and relation with MDADI scores 
 MDADI Score 





 M (SD) M (SD) t statistic  
p value 
Take longer time to eat because of swallowing problem 
(n = 48) 
88.2 (11.4) 73.0 (15.9) < .0001 
Difficulty swallowing liquids (n = 21) 82.4 (15.3) 75.8 (16.0) .086 
Difficulty swallowing solids (n = 65) 87.8 (11.9) 77.2 (16.2) .001 
Difficulty swallowing medications (n = 47) 84.7 (14.0) 76.7 (16.5) .010 
Gurgley or wet voice during or after eating (n = 5) 81.8 (15.2) 64.8 (17.3)  .017 
Coughing, throat clearing, or choking before, during, or 
after eating (n = 46) 
86.3 (12.6) 74.6 (16.6) .0001 
Inability to control food, liquid, or saliva in the mouth (n 
= 28) 
83.3 (14.2) 75.0 (17.8) .017 
Sneezing during or after a meal (n = 12) 81.8 (14.5) 74.8 (22.1) .142 
Pain or pressure in the throat or chest during swallowing 
(n = 40) 
85.9 (14.0) 73.5 (15.1) < .0001 
Wheezing after eating (n = 6) 82.4 (14.2) 58.0 (20.6) .0001 
Food comes out of nose while eating (n = 3) 81.6 (15.2) 60.0 (17.8) .018 
A need to chew excessively in order to swallow safely (n = 
55) 
90.0 (10.3) 73.5 (15.4) < .0001 
Dry mouth (n = 97) 78.5 (24.6) 81.1 (15.3) .748 
Difficulty placing food in mouth (n = 3) 81.2 (15.8) 73.3 (7.4) .393 
Sensation of food sticking in throat (n = 62) 88.7 (12.8) 76.1 (15.4) < .0001 
Forcibly regurgitate food stuck in throat (n = 18) 83.9 (13.4) 67.7 (18.6) < .0001 
Avoid eating certain foods because of swallowing 
disorder (n = 41) 
87.8 (11.6) 71.0 (15.5) < .0001 
Increased mucous or phlegm in throat before, during, or 
after eating (n = 30) 
83.8 (13.8) 74.3 (17.8) .005 
Take smaller bites of food to swallow safely (n = 55) 90.5 (9.7) 73.1 (15.3) < .0001 





     
ESSPRI severity scores (p = .004), and the question regarding overall SS severity (p = 
.032). 
To assess the relationship between daily, overall health and the potential effects 
on swallowing, SS severity, and quality of life, an additional single-question measure was 
used.  The variable about “how you feel, overall, on a daily basis” was independently 
significantly associated with two swallowing symptoms: food getting stuck in the throat 
and having mucous/phlegm while eating.  Of those who reported food stuck in throat, 
95.2% with good/fair/poor health compared with 4.8% with excellent health (MH χ2 p = 
.025).  Of those who reported mucous/phlegm while eating, 100% had good/fair/poor 
health compared with 0% with excellent health (p = .021).  Along with specific 
swallowing symptoms, “how you feel...” was compared with reporting a swallowing 
disorder and the MDADI.  “How you feel...” was statistically associated with the 
MDADI (p = .024) but not with reporting a current swallowing disorder (p = .255). 
 The SF-36 general quality of life measure was compared with current swallowing 
disorders and current swallowing symptoms.  The two summary measures of the SF-36 
are physical health and mental health.  Each summary measure is associated with four 
subscales (physical health: physical function, role-physical, bodily pain, general health; 
mental health: vitality, social functioning, role-emotional, mental health).  The raw scores 
from the survey are coded into a 0–100 scale, with 100 representing the highest state of 
health.  Average scores for each of the scale items across all participants have been 
reported previously, ranging from the 70s for general health, bodily pain, and 
energy/fatigue, to the 80s for social functioning, physical functioning, role limitations – 
physical health, and emotional well-being to the 90s for role limitations – emotional 
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stresses.  The highest possible score for physical functioning is obtained by performing 
all types of physical activity including the most vigorous without limitations due to 
health; for role-physical is obtained by having no problems with work or other daily 
activities; for bodily pain is obtained by having no pain or limitations due to pain; for 
general health is obtained by evaluating personal health as excellent; for energy/fatigue is 
obtained by feeling full of pep and energy all the time; for social functioning is obtained 
by performing normal social activities without interference due to physical or emotional 
problems; for role – emotional is obtained by having no problems with work or other 
daily activities; and for mental health is obtained by feeling peaceful, happy, and calm all 
of the time.  Of the eight subscales, reporting a swallowing disorder was significantly 
associated with two: mental health (M = 72.5, SD = 17.9, p = .042) and general health (M 
= 33.9, SD = 20.1, p = .023).  The relationship between reporting a swallowing disorder 
and the physical (p = .060) and mental health (p = .085) summary measures of the SF-36 
approached significance.  As detailed in Table 13, a logistics model showed that six 
swallowing symptoms were independently associated with the SF-36 subscales.  These 
symptoms seem to disproportionately contribute to reductions in specific aspects of 
quality of life including bodily pain and vitality.  For the model with summary physical 
health as the dependent variable, only food sticking in throat (slope = -9.4, SE = 4.8, p = 
.009) was independently associated.  For the model with summary mental health as the 
dependent variable, difficulty swallowing medication (slope = -7.2, SE = 3.5, p = .046), 
wheezing while eating (slope = -31.2, SE = 7.5, p = .001), and mucous/phlegm while 
eating were independently associated (slope = -8.6, SE = 3.9, p = .038). 





     5
5 
 
Table 13. Mean SF-36 subscale scores according to current swallowing symptoms 
Symptom (n) PF  RP  BP  GH  VT  SF  RE  MH  
 
Slope 















Longer time to eat (48) 
  
                
Difficulty swallowing liquids (21)                 
 
Difficulty swallowing solids (65) 
                
 
Difficulty swallowing meds (47) 
        -10.5 
(4.6) 
.023       
 
Gurgley/wet voice with eating (5) 
                
 
Cough/ throat clear/ choke with eating 
(46) 
                
 
Unable to control food/ liquid/ saliva in 
mouth (28) 
                
 
Sneezing with eating (12) 
    -9.8 
(7.4) 
.049           
 
Throat/chest pain/ pressure during 
swallowing (40) 
                 
 
Wheezing after eating (6) 










Food comes out nose while eating (3) 
                
 
Excessive chewing to swallow safely (55) 
        
    
    
 
Dry mouth (97) 
        
  
      
 
Difficulty placing food in mouth (3) 
                
 
Food sticking in throat (62) 
-13.2 
(5.9) 
.029     -14.6 
(4.1) 
.001         
 
Need to forcibly regurgitate food stuck in 
throat (18) 
                
 
 






Table 13. Continued 
 
Symptom (n) PF  RP  BP  GH  VT  SF  RE  MH  
 
Slope 
















Avoid eating certain foods due to poor 
swallowing (41) 
                
 
Increased mucous/ phlegm in throat 
with eating (30) 
    -15.2 
(5.1) 
.011           
 
Smaller bites of food to swallow safely 
(55) 
    -7.5 
(5.3) 
.002           
Note. Only significant slope estimates appear in the table, p < .05. 
Physical Health: Physical Function (PF), Role-Physical (RP), Bodily Pain (BP), General Health (GH) 





     
sought professional help to treat their swallowing problem.  Of those who sought help, 21 
saw a physician, five saw a speech-language pathologist, three saw a dietician, and three 
saw another provider.  Fifty-six percent indicated that it helped their swallowing (15/27), 
and half received a diagnosis (14/27 = 52%).  Seeking professional help to treat their 




 Combined Voice and Swallowing Disorders 
 To assess the comorbidity of voice and swallowing disorders in SS, frequency 
counts were undertaken.  Table 14 outlines the number of participants who reported both 
voice and swallowing disorders, one of these, or neither.  Overall, 41 (40.6%) reported 
both current voice and current swallowing disorders.  Of the 60 participants who reported 
a current voice disorder, 41 (68.3%) also reported a current swallowing disorder.  Of the 
65 participants who reported a current swallowing disorder, 41 (63.1%) also reported a 
current voice disorder.  These results suggest an association between voice and 
swallowing disorders in the SS population. 
 
 
Table 14. Prevalence of combined current  
voice and swallowing disorders 
Current Voice Disorder Current Swallowing Disorder n (%) 
Yes Yes 41 (40.6) 
Yes No 19 (18.8) 
No Yes 24 (23.8) 









 The current study describes self-reported data from an epidemiologic study of 
swallowing disorders in SS.  Prevalence, potential risk factors, and effects on quality of 
life were analyzed.  The majority (64%) of participants with SS reported a current 
swallowing disorder.  Most of these swallowing disorders began gradually (85%), were 
chronic, lasting 4 weeks or more (91%), and in many cases were longstanding (i.e., 85% 
persisted for 1+ years).  The likelihood of reporting a current swallowing disorder was 
associated with increasing disease severity of SS, but interestingly was not associated 
with the age of the participants.  One demographic variable, being male, was significantly 
associated with reporting a swallowing disorder.  One other autoimmune condition, 
MCT, was also associated with reporting a swallowing disorder.  These results confirm 
that chronic, longstanding swallowing disorders are common in SS, and appear to be 
related to worsening disease severity.  Differences in prevalence rates were not observed 
between primary SS and when the disease coexisted with RA, which was the most 
frequently co-occurring autoimmune condition. 
Patients with SS reported a high prevalence of swallowing symptoms (98% 
reported at least one), which often occurred on a daily and/or weekly basis.  Increased 
likelihood of reporting a current swallowing disorder was associated with 13 of the 19 
swallowing symptoms studied.  The five most reported symptoms were dry mouth 
(reported by 96%), difficulty swallowing solids (64%), food sticking in the throat (61%), 
need for excessive chewing to swallow safely (55%), and taking smaller bites to swallow 
safely (55%).  Only one symptom, sneezing while eating, was significantly associated 
with having SS longer.  Reporting symptoms and increased frequency of symptoms were 
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significantly associated with SS severity, suggesting that worsening of SS severity is 
associated with increased prevalence of swallowing symptoms and disorders.  
Specifically, SSI was associated with four symptoms, ESSPRI was associated with three, 
and the question regarding overall disease severity was associated with three.   
This study also examined associated medical conditions and potential risk factors 
that potentially contributed to swallowing disorder reporting.  Certain medical conditions 
and lifestyle or occupational factors increased vulnerability for experiencing a 
swallowing disorder.  Based upon inspection of the RR data, several interesting factors 
emerged.  Some risk factors were laryngeal irritants, such as current exposure to 
secondary tobacco smoke, postnasal drip, and esophageal reflux.  These irritants expose 
the laryngeal structures to potential inflammation within the upper aerodigestive tract 
and, therefore, may contribute to swallowing dysfunction.  These irritants may also 
contribute to another risk factor, frequent throat-clearing, which may be a way the body 
attempts to clear these irritants or a way to compensate for dryness or laryngeal 
dysfunction associated with SS.  Several other risk factors that were statistically 
associated with reporting a swallowing disorder included neck/throat tension and voice 
problems lasting longer than 4 weeks.  These risk factors seem to have anatomical 
connections to structures involved in swallowing.  The voice-related risk factor noted 
here demonstrates the potential effects of voicing on swallow function, again possibly 
due to related anatomy, and the comorbidity of voice and swallowing disorders in this 
group.   
Of the medical, occupational, and lifestyle risk factors considered, 51% of them 
were associated with at least one, and up to seven, swallowing symptoms.  Such a 
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diversity of risk factors may indicate that SS may be the true risk factor for swallowing 
symptoms, with increased prevalence of symptoms with additional medical and lifestyle 
components.  However, several interesting factors were associated with having more, or 
more frequent, symptoms.  As discussed above regarding risk factors for reporting 
swallowing disorders, some were potentially damaging laryngeal irritants, including 
esophageal reflux, acidic foods that may be related to reflux, frequent sinus infections, 
and past exposure to secondary tobacco smoke.  These irritants may also contribute to 
another risk factor, frequent coughing, which is the body’s defense mechanism against 
irritants.  Some voice-related risk factors–current choral singing, past church singing, and 
past volunteer activities–may again reflect the frequent comorbidity of voice and 
swallowing disorders in this population, and the shared anatomy involved in both voice 
and swallowing function.  Four symptoms were not found to have risk factors of those 
examined, and three of these four were some of the same symptoms not associated with 
reporting a swallowing disorder: wet/gurgley voice while eating, sneezing while eating, 
and dry mouth.  Since dry mouth is a hallmark of SS, the finding that it is not 
significantly associated with risk factors or reporting a swallowing disorder is interesting.  
This finding may be related to the high rate (75%) at which the participants were 
medicated for SS and the description of the participant group being of moderate SS 












Effects of Swallowing Symptoms and Disorders  
on Quality of Life in SS 
Our cohort reported high rates of undesirable swallowing disorders and related 
swallowing symptoms, and this high frequency of swallowing-related problems may help 
to explain some of the detrimental effects on quality of life reported by the participants.  
Inspection of the MDADI results revealed that swallowing disorders associated with SS 
produced mild to moderate reductions in swallowing-related quality of life.  Lower 
MDADI scores were associated with increasing severity of SS.  Our finding that SS 
severity was not correlated with years with SS, but was correlated with lower MDADI 
scores, is important.  As with the voice results, this indicates that a person with SS can 
experience lower swallowing-related quality of life at any time point along their disease 
process.   
The SF-36 general health quality of life measure also revealed important findings.  
Those who report a swallowing disorder also have poorer quality of life scores on two of 
the SF-36 subscales versus those who do not report a swallowing disorder.  Together, 
these two associated subscales represent both the physical and mental health summary 
measures.  Although statistical significance was not found between reporting a 
swallowing disorder and all SF-36 subscales, some swallowing symptoms were 
statistically significant: difficulty swallowing medications, sneezing while eating, 
wheezing while eating, food stuck in the throat, mucous/phlegm while eating, and need to 
take smaller bites.  Of these symptoms, those independently associated with reduced SF-
36 physical and mental health summary measures were difficulty swallowing 
medications, wheezing with eating, food stuck in the throat, and mucous/phlegm while 
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eating.  Interestingly, the symptom that seems most related to SS, dry mouth, was not 
significantly associated with subscales or summary measures of the SF-36.  As 
mentioned above, this was also the case when analyzing symptoms significant for 
reporting a swallowing disorder.   
The additional quality of life variable, “how do you feel, overall, on a daily 
basis,” was not significantly correlated with reporting a swallowing disorder.  However, 
it was associated with the MDADI.  This question was significantly associated with two 
of the same symptoms associated with both the MDADI and the SF-36: food stuck in the 
throat and mucous/phlegm while eating.  These two symptoms may be related to the high 
rate of reflux that is associated with swallowing problems in this population. 
Although 64% of participants reported a swallowing disorder and MDADI scores 
for these participants were lower, only 27% had ever sought professional help to treat 
their swallowing disorder.  Seeking professional help was associated with a history of 
ulcers and chest/thoracic surgery.  One possible explanation for this low rate of seeking 
treatment may be limited education regarding prevalence of and treatment for swallowing 
disorders in this population, as well as limited treatment options.  Although the average 
swallowing problem in this population appears to be moderately severe, additional health 
concerns associated with SS may consume more health-seeking resources.  However, 
regression analysis suggested that as SS severity worsens, so do swallowing disorders.  
The participants in this study reported moderate average SS severity. Perhaps swallowing 
problems and quality of life ratings would be negatively impacted in an individual whose 
SS is more severe.  This finding is important for health professionals to consider for 
treatment paradigms.  Importantly, 56% of treatment-seeking participants indicated 
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improvement following treatment.  Improved treatment options for this population would 
likely improve success rate of treatment.       
Further research surrounding swallowing disorders in SS is warranted due to these 
quality of life findings.  Swallowing disorders statistically impacted the MDADI and 
portions of the SF-36.  SS severity was statistically associated with reporting a 
swallowing disorder and subsequently impacted MDADI.  Various swallowing symptoms 
were also statistically correlated with reporting a swallowing disorder, along with all 
disease severity and quality of life measures.  Additional research in this area to further 
analyze the correlations between swallowing disorders, symptoms, and quality of life 
may demonstrate additional correlations with the SF-36.  As with voice disorders 
research in SS, there is a need for continued research investigating novel treatment 
options for swallowing disorders in this population.           
 
 
Comparisons with the Extant Literature 
In reviewing the extant literature in the area of swallowing disorders in SS, the 
studies critiqued in Table 1 could not be directly compared to the current study due to 
low numbers of SS in the rheumatic groups studied, methodology differences, and/or 
differences in definition of a swallowing disorder.  Therefore, loose comparisons were 
made.  The high prevalence for swallowing disorders in SS found in the current study 
(64%) is similar to the range of 65 to 71% previously reported by participants in other 
studies (Mandl et al., 2007; Ruiz Allec et al., 2011).  Prevalence was similar even though 
these two studies included only 20 and 31 SS participants, respectively, and they defined 
swallowing disorders differently.  Though the current study did not use objective 
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measures as in other studies, a common report among most of the swallowing-related 
studies in Table 1 is that dysphagia is significant in SS (Mandl et al., 2007; Rhodus et al., 
1995; Ruiz Allec et al., 2011).  The prevalence of swallowing symptoms has been 
reported at 80–100% (Doig et al., 1971; Mandl et al., 2007; Rogus-Pulia & Logemann, 
2011).  Similarly, the current study found at least one symptom of dysphagia in 98% of 
participants.  Dry mouth was reported by 96% of participants in the current study; Doig et 
al. (1971) and Mandl et al. (2007) did not include this symptom, and their prevalence of 
symptoms was 81 and 80%, respectively.  It is also important to note that the SS 
diagnostic criteria used by Doig et al. (1971) differs greatly from that used in the current 
study, which followed more recent guidelines.  Additionally, both the Doig et al. (1971) 
and the Mandl et al. (2007) studies included a smaller number of participants than the 
current study (53 SS and 20 SS, respectively, of 101).  Some studies reported a large 
difference between perception of swallowing problems and signs of swallowing 
dysfunction as observed using objective measures of swallowing function.  Rogus-Pulia 
and Logemann (2011) reported their SS participants rated their swallowing as worse than 
the 3% found on objective measures.  Conversely, Ruiz Allec et al. (2011) found that 
swallowing problems were objectively worse than were reported (90% vs. 71%).  Both 
studies had a relatively small cohort and used a much smaller swallowing symptom 
questionnaire than the current study, asking only 12 and one swallowing-related 
question(s), respectively.  When comparing risk factors for swallowing disorders 
presented in the extant literature, reflux seemed to be the one suggested in other studies 
(Mandl et al., 2007; Ruiz Allec et al., 2011).  These reports support findings in the 
current study that found reflux to be a significant risk factor for swallowing disorders.  
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The final comparison to be made is in the area of quality of life resulting from 
swallowing disorders in SS.  No studies in Table 1 addressed socioemotional effects of 
these disorders.  
Comparisons between the current study and several non-SS studies were made to 
review interesting risk factors in the current study that were not independently associated 
with reporting a current swallowing disorder.  These factors include stroke, COPD, and 
chronic pain, which have previously been associated with reporting a swallowing 
disorder in a geriatric population (Roy et al., 2007b), although similar associations were 
not found in the current study.  Other factors not associated with reporting a current 
swallowing disorder include years with SS and current use of medication.  Although RA 
was the most common comorbid autoimmune condition, MCT was the only one 
significantly associated with reporting a swallowing disorder.  This finding may be 
important as SS awareness increases with potential diagnosis of comorbid MCT, and 
future research may examine swallowing disorders in a larger cohort with this 
autoimmune condition.  In a concurrent study (Wright, 2014), RA was found to have a 
higher incidence of swallowing disorders than the general population (41% vs.12–13%; 
Groher & Bukatman, 1986), but not as high as the incidence found in SS with or without 
comborbid RA in the current study.  Increased age has also been associated with 
increased prevalence of swallowing disorders compared with the general population 
(33% in age 65+ vs. 12–13%, respectively; Groher & Bukatman, 1986; Roy et al., 
2007b).  The majority of participants in the current study (78%) were aged 60+, and 
statistical analyses did not result in a correlation between increased age and increased 
prevalence of swallowing disorders.  SS seems to be associated with a higher prevalence 
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of swallowing disorders than both the general population and the geriatric population.  
This seems to show that SS severity is the true risk factor for reporting a swallowing 




















 This study, based on self-report data from a large SS cohort, revealed a high rate 
of voice and swallowing disorders and symptoms, and their possible negative influence 
on quality of life.  Various medical, lifestyle, and personality risk factors were associated 
with reporting these disorders and symptoms.  Correlations between voice and 
swallowing disorders and SS severity were also found.  It appears that SS severity 
contributes to reductions in voice- and swallowing-related quality of life.  Our results 
contribute to and expand those from previous studies and suggest a greater need for 
education and awareness of voice and swallowing disorders in the SS population.  These 
results, combined with a low rate of seeking treatment, demonstrate the need for 
awareness of voice and swallowing disorders at any stage of this disease.  Additionally, 
research in this area should continue to better understand the nature and relationship 
between comorbid voice and swallowing disorders, symptoms, and resulting quality of 
life.   
 














EPIDEMIOLOGY OF VOICE AND SWALLOWING DISORDERS IN 
































Date: _____________     START TIME  __ __ : __ __  am     Survey administrator: ____________________ 
                                                  pm 
 
To start, I have a few questions about you. 
 
1. What is your date of birth? 
   
  ___ / ___ / ___ 
   Mo.     Day      Yr. 
 
2. How many years of schooling have you completed including any college, vocational, or technical training? 
 
  ________ [ACTUAL # OF YEARS] 
 
  12 = High School (includes GED) 
  14 = Associate Degree 
  16 = B.A., B.S. 
  18 = M.A., M.S. 
  20 = Ph.D., M.D., J.D., etc. 
  
3. a.   What is your race or ethnicity?  Are you …(read list) 
   1 = White, 
   2 = Black or African American, 
   3 = Native Hawaiian or Pacific Islander, 
   4 = Asian, 
   5 = Native American or Alaska Native, or 
   6 = Hispanic 
   7 = Something else?  (Specify: ____________________________) 





b.   Are you Hispanic or of Spanish origin? 
 
   1 = Yes 
   0 = No 
 
4. Which of the following categories best describes your current household yearly gross income (before taxes for everyone who 
lives with you)?  … 
  
    1 = Under $20,000, 
    2 = From $20,000 to $40,000, 
    3 = From $40,000 to $60,000, or  
    4 = More than $60,000? 
    5 = DON’T KNOW 
    6 = PREFER TO NOT ANSWER





This first section of the interview relates to your health and medical history during your entire life. 
 
5.  a.  During your entire life, have you ever had… 
 
  1 = Yes (IF YES, CONTINUE 5b-5e) 
  0 = No (GO TO NEXT MEDICAL CONDITION) 
  7 = Don’t Know 
  9 = Refused to answer 
 
b. What year did you first have (this condition)? 
__ __ __ __ 
 
c. Are you currently taking medications for this condition? 
 
1 = Yes 
0 = No 
 
d. In what year did you first start taking this medication? 
 








 Yes No DK Ref Year Yes No  
Arthritis? 1 0 7 9 __ __ __ __ 1 0 __ __ __ __ 
Sjogren’s Syndrome? 
Rheumatoid Arthritis? 





1 0 7 9 __ __ __ __ 1 0 __ __ __ __ 


















Heart disease 1 0 7 9 __ __ __ __ 1 0 __ __ __ __ 
Hypertension / high 
blood pressure 
1 0 7 9 __ __ __ __ 1 0 __ __ __ __ 
Circulatory problems 1 0 7 9 __ __ __ __ 1 0 __ __ __ __ 
Kidney problems 1 0 7 9 __ __ __ __ 1 0 __ __ __ __ 
Thyroid problems 
     If YES  







1 0 7 9 __ __ __ __ 1 0 __ __ __ __ 
Stomach or duodenal 
ulcer 
1 0 7 9 __ __ __ __ 1 0 __ __ __ __ 
Esophageal reflux, 
such as burning, 
burping acid taste, or 
acid indigestion? 
1 0 7 9 __ __ __ __ 1 0 __ __ __ __ 
Stroke 1 0 7 9 __ __ __ __ 1 0 __ __ __ __ 
Respiratory allergies? 1 0 7 9 __ __ __ __ 1 0 __ __ __ __ 





  (IF YES) Are they… 
   1 =  seasonal 
   2 =  non-seasonal 
Pneumonia 1 0 7 9 __ __ __ __ 1 0 __ __ __ __ 




1 0 7 9 __ __ __ __ 1 0 __ __ __ __ 








Bronchitis 1 0 7 9 __ __ __ __ 1 0 __ __ __ __ 
Asthma 1 0 7 9 __ __ __ __ 1 0 __ __ __ __ 
Severe neck, back, or 
head injury 
1 0 7 9 __ __ __ __ 1 0 __ __ __ __ 
Chronic pain 1 0 7 9 __ __ __ __ 1 0 __ __ __ __ 
Cancer 1 0 7 9 __ __ __ __ 1 0 __ __ __ __ 
Depression or anxiety 1 0 7 9 __ __ __ __ 1 0 __ __ __ __ 
Sleep disorder 1 0 7 9 __ __ __ __ 1 0 __ __ __ __ 
 
 
6. On average, how many times a year do you get (CONDITION)? 
  
 Would you say never, less than once a year, once or twice a year, 3 to 5 times, 6 to 8 times, or more than 8 times a year? 
 
Condition Never <1 1-2 3-5 6-8 >8 
a. colds? 0 1 2 3 4 5 
b. sinus infections? 0 1 2 3 4 5 





c. sore throats? 0 1 2 3 4 5 
 
7. Do you have post-nasal drip … 
 
1 = Chronically, 
2 = Seasonally, 
3 = Occasionally with colds, or 
4 = Not at all? 
 
8. Have you ever had surgery?  
 
1 = YES   
0 = NO   (if no, skip to question 9) 
 
Surgery Yes No 
a. Head and neck surgery 1 0 
b. Chest / Thoracic surgery 1 0 
c. Abdominal surgery 1 0 





9. Did any of your surgeries or hospitalizations require you to be on a respirator / ventilator / breathing machine or trach?  
 
1 = YES 
0 = NO  
 
10. CODE SEX.  ASK IF UNSURE:  Are you… 
 





0 = Male or  (GO TO Q12) 
1 = Female? 
 
11. [FOR WOMEN ONLY] 
 
a. Have you stopped having menstrual periods? (If NO, go to Q 12) 
 
b. How many years ago did you stop menstruating?   
 
 1-2 years =  0 
            3-5 years =  1 
 6-10 years =  2 
 10+ years =  3 
  
       c.  Are you taking estrogen replacement therapy?   
 
  1 = YES  
  0 = NO (IF NO, GO TO 12) 
 
       d.   How long have you been taking replacement therapy? 
 
  1-2 years = 0 
             3-5 years =  1 
  6-10 years =  2 
  10+ years =  3 
 
12. Now we have a few questions about some of your personal habits including cigarette smoking, other tobacco use, and the use of 
alcohol. 
 
a. Have you ever used any tobacco products for a year or longer? 






1 = Yes 
0 = No (GO TO Q 13) 
 
b. Have you ever (smoked/used) [TYPE] for a year or longer? 
Yes                 No 
a. Cigarettes     1                    0 
b. Cigars                                          1                    0 
c. Pipes                                            1                    0 
d. Chewing tobacco                         1                    0 
 
 
c. What year did you first start (smoking/chewing)? 
__ __ __ __ 
 
d. Do you still (smoke/chew)? 
 
1 = Yes  (GO TO f) 
0 = No 
 
e. In what year did you stop (smoking/chewing)? 
 
__ __ __ __ 
 
f. On average, how many (cigarettes/cigars/pipefuls/pinches) (do/did) you (smoke/use) a day? 
 
      _____________________ 
 
13. a.   At any year in your life, did you drink an average of one or more alcoholic beverages a week? 
  





  1 = Yes 
  0 =  No  (GO TO Q14)  
 
b. How old were you when you first started drinking alcoholic beverages regularly?  
 
__ __ years  
 
c. Do you still drink?  [THIS MEANS ANY AMOUNT OF ALCOHOL] 
 
1 = Yes  (GO TO e) 
0 = No 
  
 
d. What year did you stop drinking? 
__ __  __ __ 
 
e. On average, how many drinks do/did you drink in a week? 
____________ # drinks 
 
14.    a.     Have you ever used recreational drugs? 
  
1 = Yes 
0 = No (IF NO, GO TO 15)  
 
 b.  Have you ever used (TYPE) for a year or longer? 
 
  a.   Marijuana 
                        b.   Heroine 
                        c.   Cocaine 
                        d.   LSD 





              e.   Other. Specify       
 
c.   How old were you when you first started using recreational drugs regularly?  
 
__ __ years  
 
d.     Do you still use recreational drugs?   
 
1 = Yes  (GO TO f) 
0 = No 
 
e.     What year did you stop using recreational drugs? 
__ __  __ __  
 
f.      On average, how many times do / did you use recreational drugs in a week? 
____________ # of times 
 
 
15. How often do you use / partake of the following items? (read “constantly, often…never”) 
 
Activity Constantly Often Occasionally Rarely Never 
a. Coffee 5 4 3 2 1 
b. Tea 5 4 3 2 1 
c. Colas 5 4 3 2 1 
d. Chocolate 5 4 3 2 1 
e. Dairy Products 5 4 3 2 1 





f. Mint Products 5 4 3 2 1 
g. Acidic Foods 5 4 3 2 1 
h. Spicy Foods 5 4 3 2 1 
i. Water 5 4 3 2 1 
 
16.   How often do you experience tension in the following areas? (read “constantly, often…never”) 
 
Activity Constantly Often Occasionally Rarely Never 
a. Neck / Throat 5 4 3 2 1 
b. Jaw 5 4 3 2 1 
c. Shoulders 5 4 3 2 1 
d. Abdomen 5 4 3 2 1 
 
 
17. Now I would like to ask you some questions about your voice.  For the purpose of this study, we consider a voice problem to be 
any time your voice does not work, perform, or sound as you feel it normally should, so that it interferes with communication. 
 
a. Do you currently have a voice problem like this? 
 
1 = Yes (continue to 17b below) 
0 = No (skip to 18) 
 
b. Did the problem begin suddenly or gradually? 
 
1 = Suddenly 





0 = Gradually 
 
c. Has this problem lasted for more than 4 weeks? 
 
1 = Yes  
0 = No (IF NO – GO TO 18) 
 
d. When did you first notice the problem? 
 
1 = 1-6 months ago   
2 = 7-12 months ago   
 3 = 1-3 years ago    
 4 = 4-9 years ago    
 5 = 10+ years ago     
 
18.   a.   Have you ever had a voice problem like this in the past? 
 
1 = Yes 
0 = No (GO TO Q 19a) 
  
b.   Approximately what year did you first notice that you had a voice problem? 
 
__ __ __ __ 
 
c.  Did this problem last for 4 weeks or more? 
 
1 = Yes (CHRONIC) 
0 = No (ACUTE) 
 
d.   Did the problem begin gradually or suddenly? 






1 = Gradually 
2 = Suddenly 
 
e.  Have you had any voice problems since that time? 
 
1 = Yes 
0 = No (GO TO Q 19) 
f.  Have your voice problems been … 
 
1 = continual, or 
0 = off and on? 
  
g.    Have you ever seen a doctor or speech pathologist about any type of voice 
    problem? 
 
1 = Yes 
0 =  No (GO TO Q 19) 
 
 h.   What year did you first see a doctor or speech pathologist about a voice problem? 
  __ __  __ __ 
 




19.  Do you have a family history of any type of voice problem? 
 
1 = Yes 
0 = No 





 20.   Now, I will read a list of voice symptoms.  For each one, please tell me if you have ever had that symptom. 
 
a. Have you ever had (SYMPTOM)? 
 
1 = Yes 
0 = No (GO TO NEXT SYMPTOM) 
 
b. Do you have this symptom currently? 
 
1 = Yes 
0 = No 
 
c. How often do you have this (symptom)?  Would you say … 
 
1 = daily, 
2 = weekly, 
3 = monthly, 
4 = several times a year, or 
5 = yearly or less?   
 
d. Do you think this (symptom) is the result of your job? 
 
1 = Yes 












Yes No Yes No Dy Wk Mn Sev Yr Yes No 
aa.  Hoarseness? 1 0 1 0 1 2 3 4 5 1 0 














Yes No Yes No Dy Wk Mn Sev Yr Yes No 
ab.  Your voice tire or 
change quality after using 
it for even a short time? 
1 0 1 0 1 2 3 4 5 1 0 
ac.  Trouble speaking or 
singing softly? 
1 0 1 0 1 2 3 4 5 1 0 
ad.  Difficulty projecting 
your voice? 
1 0 1 0 1 2 3 4 5 1 0 
ae.  A loss of singing 
range? 
1 0 1 0 1 2 3 4 5 1 0 
af.  Discomfort while 
using your voice? 
1 0 1 0 1 2 3 4 5 1 0 
ag.  A monotone voice 
(monopitch)? 
1 0 1 0 1 2 3 4 5 1 0 
ah.  To make an effort to 
talk? 
1 0 1 0 1 2 3 4 5 1 0 
ai.  Chronic dryness in 
your throat? 
1 0 1 0 1 2 3 4 5 1 0 
aj. Wet, gurgley voice 
quality 
1 0 1 0 1 2 3 4 5 1 0 
ak.  Chronic soreness in 
your throat? 
1 0 1 0 1 2 3 4 5 1 0 
al.  To frequently clear 
your throat? 
1 0 1 0 1 2 3 4 5 1 0 
am.  A bitter or acid taste? 1 0 1 0 1 2 3 4 5 1 0 





an.  Wobbly or shaky 
voice? 
1 0 1 0 1 2 3 4 5 1 0 
ao. An “airy” or “breathy” 
voice? 
1 0 1 0 1 2 3 4 5 1 0 
 
21. Next, I will read a list of activities.  For each one, please tell me whether you do this constantly, often, occasionally, rarely or 
never during an average day. 
 
How frequently do you (ACTIVITY) during an average day?  Would you say constantly, often, occasionally, rarely or never? 
 
 
Activity Constantly Often Occasionally Rarely Never 
a. Talk 5 4 3 2 1 
b. Talk quietly 5 4 3 2 1 
c. Whisper 5 4 3 2 1 
d. Talk loudly 5 4 3 2 1 
e. Sing 5 4 3 2 1 
f. Shout, yell, or 
cheer 
5 4 3 2 1 
g. Clear your 
throat 
5 4 3 2 1 
h. Laugh 5 4 3 2 1 
i. Cough 5 4 3 2 1 
 
 





22. Some people use / have used their voices for other activities.  
 
a. Do you currently participate in (ACTIVITY)?  
 
1 = YES 
0 = NO 
 
b. In the past, have you participated in (ACTIVITY)? 
 
1 = YES 
0    = NO 
 
Activity Current Past 
Yes No Yes No 
aa. choral singing 1 0 1 0 
ab. singing at church 1 0 1 0 
ac. solo singing 1 0 1 0 
ad. stage acting 1 0 1 0 
ae. public speaking 1 0 1 0 
af. volunteer activities 1 0 1 0 
  
 
23. Now we would like some information about your work history. Some occupations require extensive voice use such as sales, 
teaching, broadcasting, clergy, telephone operator, or receptionist.  
 
a. Are / were you ever employed in a job that required you to talk a lot on a daily basis? 
 
1 = Yes  
0 = No (IF NO, GO TO 24) 






b. How many years have you been / were you employed in this type of job? 
 
 1 = 0 – 9 
 2 = 10 – 19 
 3 = 20 – 29 
 4 = 30 – 39 
 5 = 40+ 
 
c.    What is / was your job title?       
 




 e..    Do / Did you experience any voice problems with this job? 
 
  1 = YES 
  0 = NO (IF NO, GO TO h) 
 
 f..    How long did the problem last? Would you say… 
 
  1 = A few days 
  2 = A few weeks 
  3 = A few months, or 
  4 = A year or more 
 
g.   Would you say… 
 
1 = your voice limits / limited your ability to do certain tasks in this job? 





2 = your voice makes / made you unable to do certain tasks 
3 = your voice does not / did not affect your ability to do various tasks 
 
h.    Did you ever change (IF EMPLOYED or feel you need to change) your occupation or job because of your voice? 
 
  1 = YES 
  0 = NO 
 
i. Did you have to retire or take disability due to your voice problem? 
 
1 = YES 
0 = NO 
 
24.   a.   Have you ever sought professional help to improve your voice in any way? 
  
1 = Yes 
0 = No  (GO TO Q 25) 
 
 b.   Did you see …   [CIRCLE ALL THAT APPLY] 
 
   1 = a speech or language pathologist, 
   2 = a physician, 
   3 = a singing or acting teacher or coach, or  
   4 = someone else? Specify________________________ 
 
 c.   Did it help you? 
 
   1 = Yes 
   0 = No 
 





25. We are interested in whether you have ever been exposed to any of the following? 
 
a. Are you currently exposed to (ITEM)? 
 
1 = YES 
0 = NO 
 
b. Have you ever been exposed to (ITEM)? 
 
1 = YES 
0 = NO 
 
 
Exposure Current Past 
Yes No Yes No 
aa. Excess Dust 1 0 1 0 
ab. Fumes from cleaning 
products 
1 0 1 0 
ac. Secondary tobacco 
smoke 
1 0 1 0 
ad. Dry air 1 0 1 0 
ae. Other. Specify________ 
______________________ 
 
1 0 1 0 
 





26. I will now ask you 10 questions about problems you may be having with your voice. Each question will ask you to rate the 
severity of the problem for you. To determine how “bad” it is, think of both how often the problem occurs and how severe it is when it 
happens. Rate each question on a 5-point scale below, with “5” being the worst possible. Your answers should be based on your 
average voice quality over the past 2 weeks or so. (Read the 5-point scale when completing this section.) 
 
 1 = None, not a problem 
 2 = A small amount 
 3 = A moderate (medium) amount 
 4 = Frequently 
 5 = As bad as it can be 
 
Read “Because of your voice” prior to each question; (give options “none, small amount…as bad as can be” for each question) 
 




Freq. As bad as 
can be 
a. Do you have trouble speaking loudly or being heard in 
noisy situations? 
1 2 3 4 5 
b. Do you run out of air and need to take frequent breaths 
when talking? 
1 2 3 4 5 
c. You do not know what will come out when you begin 
speaking? 
1 2 3 4 5 
d. Do you get anxious or frustrated? 1 2 3 4 5 
e. Do you get depressed? 1 2 3 4 5 
f. Do you have trouble using the telephone? 1 2 3 4 5 
g. Do you have trouble doing your job or practicing your 
profession? (Indicate if not applicable ____NA) 
1 2 3 4 5 
h. Do you avoid going out socially? 1 2 3 4 5 
i. Do you have to repeat yourself to be understood? 1 2 3 4 5 
j. Have you become less outgoing? 1 2 3 4 5 






Now, I would like to ask you some questions about your ability to swallow. For the purpose of this study we consider a swallowing 
problem to be anytime when you experience difficulty moving food or liquid from your mouth to your stomach or anytime you 
experience choking or frequent throat clearing during or following mealtime.  
 
27a. Do you currently have a swallowing problem like this? 
 
 1 = Yes 
 0 = No (Skip to 28a) 
 
    b. Did the swallowing problem begin suddenly or gradually? 
 
 1 = suddenly  
 0 = gradually 
 
    c. Has this swallowing problem lasted for more than 4 weeks? 
 
 1 = Yes 
 0 = No (IF NO, GO TO 28) 
 
    d. When did you first notice that you have this swallowing problem? 
 
 1 = 1-6 months 
 2 = 7-12 months 
 3 = 1-3 years 
 4 = 4-9 years 
 5 = 10+ years 
 
e. Did your swallowing problem begin with a reaction to medicine: 
 





1 = Yes 
0 = No 
f. Did your swallowing problem begin following an illness? 
 
1 = Yes 
0 = No 
 
g. Did your swallowing problem begin following surgery? 
 
1 = Yes 
0 = No 
 
28a. Have you ever had a swallowing problem like this in the past? 
 
 1 = Yes 
 0 = No (Skip to 29) 
 
28b. Approximately what year did you notice that you had this problem? 
 
 __ __ __ __ 
 
29.  Have you ever had? 
 a. A feeding tube 
 
  1 = Yes 
  0 = No 
 
 b. A need to use nutritional supplements (e.g. Ensure, Boost) to make sure that you are taking in enough calories each day?  
 
  1 = Yes 





  0 = NO 
 
 
30. Now, I will read a list of swallowing symptoms. For each one, please tell me if you have ever had that symptom. 
a. Have you ever had (SYMPTOM)? 
  
 1 = Yes 
 0 = No (GO TO NEXT SYMPTOM) 
 
b. Do you have (SYMPTOM) currently? 
 
 1 = Yes 
 0 = No 
 
c. How often do you have (SYMPTOM)? Would you say… 
 
 1 = daily, 
 2 = weekly, 
 3 = monthly, 
 4 = several times a year, or 










Yes No Yes No Dy Wk Mn Sev Yr 
aa.  To take a longer time to 
eat because of your 
swallowing problem? 
1 0 1 0 1 2 3 4 5 
ab. Difficulty swallowing 1 0 1 0 1 2 3 4 5 






ac. Difficulty swallowing 
solids? 
1 0 1 0 1 2 3 4 5 
ad. Difficulty swallowing 
medications? 
1 0 1 0 1 2 3 4 5 
ae. A gurgley or wet voice 
during or after eating? 
1 0 1 0 1 2 3 4 5 
af. Coughing, throat clearing, 
or choking before, during or 
after eating? 
1 0 1 0 1 2 3 4 5 
ag. An inability to control 
food, liquid, or saliva in the 
mouth? 
1 0 1 0 1 2 3 4 5 
ah. Any sneezing during or 
after a meal? 
1 0 1 0 1 2 3 4 5 
ai. Pain or pressure in the 
throat or chest during 
swallowing? 
1 0 1 0 1 2 3 4 5 
aj. Wheezing after eating? 1 0 1 0 1 2 3 4 5 
ak. Food come out of your 
nose while eating? 
1 0 1 0 1 2 3 4 5 
al. A need to chew excessively 
in order to swallow safely? 
1 0 1 0 1 2 3 4 5 
am. Dry mouth? 1 0 1 0 1 2 3 4 5 
an. Difficulty placing food in 
mouth? 
1 0 1 0 1 2 3 4 5 





ao. A sensation of food 
sticking in your throat? 
1 0 1 0 1 2 3 4 5 
ap. To forcibly regurgitate 
food that is stuck in your 
throat? 
1 0 1 0 1 2 3 4 5 
aq. To avoid eating certain 
foods because of your 
swallowing disorder? 
1 0 1 0 1 2 3 4 5 
ar. Increased mucous or 
phlegm in your throat before, 
during, or after you eat? 
1 0 1 0 1 2 3 4 5 
as. To take smaller bites of 
food in order to swallow 
safely. 
1 0 1 0 1 2 3 4 5 
 
 
31. The next few questions ask about your views of your swallowing ability. This information will help us understand how you feel 
about swallowing. The following statements have been made by people who have problems with their swallowing. Some of the 
statements may apply to you. Please listen to each statement and indicate the response which best reflects your experience in the past 








a. My swallowing ability limits 
my day-to-day activities 
1 2 3 4 5 
b. I am embarrassed by my eating 
habits. 
1 2 3 4 5 
c. People have difficulty cooking 
for me. 
1 2 3 4 5 





d. Swallowing is more difficult at 
the end of the day. 
1 2 3 4 5 
e. I do not feel self-conscious 
when I eat. 
5 4 3 2 1 
f. I am upset by my swallowing 
problem. 
1 2 3 4 5 
g. Swallowing takes great effort. 1 2 3 4 5 
h. I do not go out because of my 
swallowing problem. 
1 2 3 4 5 
i. My swallowing difficulty has 
caused me to lose income? 
1 2 3 4 5 
j. It takes me longer to eat 
because of my swallowing 
problem. 
1 2 3 4 5 
k. People ask me, “Why can’t you 
eat that?” 
1 2 3 4 5 
l. Other people are irritated by my 
eating problem. 
1 2 3 4 5 
m. I cough when I try to drink 
liquids. 
1 2 3 4 5 
n. My swallowing problems limit 
my social and personal life. 
1 2 3 4 5 
o. I feel free to go out to eat with 
my friends, neighbors, and 
relatives. 
5 4 3 2 1 
p. I limit my food intake because 
of my swallowing difficulty. 
1 2 3 4 5 
q. I cannot maintain my weight 
because of my swallowing 
1 2 3 4 5 








32. Do you have a family history of any type of swallowing problem? 
 
 1 = Yes 
 0 = No 
 DK= Don’t know 
 
33. a.   Have you ever sought professional help to assess or treat your swallowing problem in any way? 
  
1 = Yes 
0 = No  (GO TO Q 34) 
 
 b.   Did you see …   [CIRCLE ALL THAT APPLY] 
 
   1 = a speech or language pathologist, 
   2 = a physician, 
   3 = a dietician, or  
   4 = someone else? Specify________________________ 
 
 c.   Did it help you? 
 
   1 = Yes 
problem. 
r. I have low self-esteem because 
of my swallowing problem. 
1 2 3 4 5 
s. I feel that I am swallowing a 
huge amount of food. 
1 2 3 4 5 
t. I feel excluded because of my 
eating habits. 
1 2 3 4 5 





   0 = No 
  
 d. Did you ever receive a diagnosis related to your swallowing? 
 
   1 = Yes 
   0 = No (Go To Q 34) 
 
 e. What was the diagnosis you received? _________________________ 
 
 
34. a. Do you live alone? 
 
 1 = Yes (IF YES, GO TO 35) 
 0 = No  
 
 b. How many people (including you) live in your home? ____ (insert #) 
 
35.  a. Do you have a hearing loss?  
 
 1 = Yes 
 0 = No (IF NO, GO TO 36) 
 
     b. Do you wear hearing aids on a regular basis? 
 
1 = Yes 
0 = No 
 
36.  a. Do you exercise? 
 
 1 = Yes 





 0 = No (GO TO 37) 
 
 b. How often do you exercise? 
 
  1 = 1-2 X week 
  2 = 3-4 X week 





37.  Overall, how do you feel on a daily basis? 
 
 1 = excellent 
 2 = good 
 3 = fair 
 4 = poor 
 
 
38. Would you describe yourself as … 
 
a. Quiet or talkative 
 
1 = Quiet 
0 = Talkative 
 
b. Easy-going or a worrier 
 
1 = Easy-going 
0 = Worrier 






 c.  Active or inactive 
 
  1 = Active 
  0 = Inactive 
 
d. Happy or sad 
 
1 = Happy 
0 = Sad 
 
  
39. What is your religious preference? 
1 =  Protestant 
2 =  Catholic 
3 =  LDS/Mormon 
4 =  Jewish 
5 =  Other 
6 =  No Religion 
7 =   Prefer not to answer 
 
40. Now I would like to ask you some questions about your speech. For the purpose of this study, we consider a speech problem to be 
any time when you experience difficulty with speech production (including slurred speech or imprecise sound production/articulation) 
so that it interferes with communication. 
 
a. Do you currently have a speech problem like this? 
 
1 = Yes (continue to 40b below) 
0 = No (skip to 41) 
 






b. Did the problem begin suddenly or gradually? 
 
1 = Suddenly 
0 = Gradually 
 
c. Has this problem lasted for more than 4 weeks? 
 
1 = Yes  
0 = No (IF NO – GO TO 41) 
 
d. When did you first notice the problem? 
 
1 = 1-6 months ago   
2 = 7-12 months ago   
 3 = 1-3 years ago    
 4 = 4-9 years ago    
 5 = 10+ years ago     
 
41.   a.   Have you ever had a speech problem like this in the past? 
 
1 = Yes 
0 = No (GO TO Q 42) 
  
b.   Approximately what year did you first notice that you had a speech problem? 
 
__ __ __ __ 
 
c. Did this problem last for 4 weeks or more? 
 
1 = Yes (CHRONIC) 






0 = No (ACUTE) 
 
d.   Did the problem begin gradually or suddenly? 
 
1 = Gradually 
2 = Suddenly 
 
e.  Have you had any speech problems since that time? 
 
1 = Yes 
0 = No (GO TO Q 42) 
 
f.  Have your speech problems been … 
 
1 = continual, or 
0 = off and on? 
  
g.    Have you ever seen a doctor or speech pathologist about any type of speech 
    problem? 
 
1 = Yes 
0 =  No (GO TO Q 42) 
 
 h.   What year did you first see a doctor or speech pathologist about a speech problem? 
 
  __ __  __ __ 
 
i.    What was the problem?   
 
___________________________________________ 







42.  Do you have a family history of any type of speech problem? 
 
1 = Yes 
0 = No 
 
43. I would like to ask you a few more questions about your general health. (READ NUMERIC CHOICES) 
(Medical Outcomes Study:  36-Item Short Form Survey Instrument (RAND 36-Item Health Survey 1.0 Questionnaire Items) 
1. In general, would you say your health is: 
Excellent 1 




2. Compared to one year ago,  
how would your rate your health in general now? 
Much better now than one year ago 1 
Somewhat better now than one year ago 2 






About the same 3 
Somewhat worse now than one year ago 4 
Much worse now than one year ago 5 
 
 
The following items are about activities you might do during a typical day. Does your health now limit you in these activities? If so, 
how much?  
(Circle One Number on Each Line)  
 
Yes, Limited a 
Lot  
Yes, Limited a 
Little  
No, Not limited 
at All  
3. Vigorous activities, such as running, lifting heavy objects, 
participating in strenuous sports  
[1]  [2]  [3]  
4. Moderate activities, such as moving a table, pushing a vacuum 
cleaner, bowling, or playing golf  
[1]  [2]  [3]  
5. Lifting or carrying groceries  [1]  [2]  [3]  






6. Climbing several flights of stairs  [1]  [2]  [3]  
7. Climbing one flight of stairs  [1]  [2]  [3]  
8. Bending, kneeling, or stooping  [1]  [2]  [3]  
9. Walking more than a mile  [1]  [2]  [3]  
10. Walking several blocks  [1]  [2]  [3]  
11. Walking one block  [1]  [2]  [3]  
12. Bathing or dressing yourself  [1]  [2]  [3]  
During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of 
your physical health?  
(Circle One Number on Each Line)  
 Yes  No  
13. Cut down the amount of time you spent on work or other activities  1  2  
14. Accomplished less than you would like  1  2  






15. Were limited in the kind of work or other activities  1  2  
16. Had difficulty performing the work or other activities (for example, it took extra effort)  1  2  
During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of 
any emotional problems (such as feeling depressed or anxious)?  
(Circle One Number on Each Line)  
 Yes No 
17. Cut down the amount of time you spent on work or other activities  1  2  
18. Accomplished less than you would like  1  2  
19. Didn't do work or other activities as carefully as usual  1  2  
20. During the past 4 weeks, to what extent has your physical health or emotional problems interfered with your normal social 
activities with family, friends, neighbors, or groups?  
(Circle One Number)  
Not at all = 1 
Slightly = 2  






Moderately = 3  
Quite a bit = 4  
Extremely = 5  
21. How much bodily pain have you had during the past 4 weeks?  
(Circle One Number)  
None = 1  
Very mild = 2  
Mild = 3  
Moderate = 4  
Severe = 5  
Very severe = 6  
 
22. During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and 
housework)?  
(Circle One Number)  
Not at all = 1  






A little bit = 2  
Moderately = 3  
Quite a bit = 4  
Extremely = 5  
These questions are about how you feel and how things have been with you during the past 4 weeks. For each question, please give 
the one answer that comes closest to the way you have been feeling.  
How much of the time during the past 4 weeks . . .  
(Circle One Number on Each Line)  
 All of the 
Time  
Most of 
the Time  
A Good Bit 
of the Time  
Some of 
the Time  
A Little of 
the Time  
None of 
the Time  
23. Did you feel full of pep?  1  2  3  4  5  6  
24. Have you been a very nervous 
person?  
1  2  3  4  5  6  
25. Have you felt so down in the dumps 
that nothing could cheer you up?  
1  2  3  4  5  6  
26. Have you felt calm and peaceful?  1  2  3  4  5  6  






27. Did you have a lot of energy?  1  2  3  4  5  6  
28. Have you felt downhearted and blue?  1  2  3  4  5  6  
29. Did you feel worn out?  1  2  3  4  5  6  
30. Have you been a happy person?  1  2  3  4  5  6  
31. Did you feel tired?  1  2  3  4  5  6  
32. During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social 
activities (like visiting with friends, relatives, etc.)?  
(Circle One Number)  
All of the time = 1  
Most of the time = 2  
Some of the time = 3  
A little of the time = 4  
None of the time = 5  
 






How TRUE or FALSE is each of the following statements for you.  











33. I seem to get sick a little easier than other 
people  
1  2  3  4  5  
34. I am as healthy as anybody I know  1  2  3  4  5  
35. I expect my health to get worse  1  2  3  4  5  
36. My health is excellent  1  2  3  4  5  
 
 
44. Lastly, we would like to ask you a few questions about your autoimmune condition. How would you rate the overall severity of 
your autoimmune condition (Sjogren’s Syndrome, Rheumatoid Arthritis, Diabetes Type 1, Wegener’s Granulomatosis, Scleroderma, 

























9=Mixed connective tissue disease 
 
CLOSING: 








The University of (Utah) thanks you for your time (today/this evening). 
 
END TIME  __ __ : __ __ am 











APPENDIX: Sjogren’s Syndrome/Wegener’s Granulomatosis 
 
Sjogren’s Questionnaire 1 
 
Please consider the past 2 weeks when rating the following: 
Sore Eyes 
0 1 2 3 4 5 6 7  




0 1 2 3 4 5 6 7  




0 1 2 3 4 5 6 7  




0 1 2 3 4 5 6 7  




0 1 2 3 4 5 6 7  
0=No problem at all       7=As bad as imaginable 
 
Bad Breath 






0 1 2 3 4 5 6 7  
0=No problem at all       7=As bad as imaginable 
 
 
Wetting Mouth (carried fluid during day/night) 
0 1 2 3 4 5 6 7  




0 1 2 3 4 5 6 7  




0 1 2 3 4 5 6 7  




0 1 2 3 4 5 6 7  
0=No problem at all       7=As bad as imaginable 
 
 
(SSI Sicca Symptoms Inventory—Short Form, Bowman et al., 2003) 
 
Sjogren’s Questionnaire 2 
Dryness 
0 1 2 3 4 5 6 7 8 9 10 
 











0 1 2 3 4 5 6 7 8 9 10 
 
(ESSPRI, Seror et al., 2011) 
 
 
APPENDIX: Rheumatoid Arthritis 
 
Rheumatoid Arthritis Pain Scale (RAPS) DIRECTIONS: The following items relate to pain and arthritis. For each item, choose one 
number from 0 (never) to 6 (always) to describe how you have felt in the last week. 
 
 0 (Never) 1 2 3 4 5 6  (Always) 
 
1. I would describe my pain as gnawing.    0  1 2 3 4 5 6 
2. I would describe my pain as aching.   0  1 2 3 4 5 6 
3. I would use the word exhausting to 
 describe my pain.      0  1 2 3 4 5 6 
4. I would describe my pain as annoying.  0  1 2 3 4 5 6 
5. I am in constant pain.    0  1 2 3 4 5 6 
6. I would describe my pain as rhythmic.  0  1 2 3 4 5 6 
7. I have swelling of at least one joint.  0  1 2 3 4 5 6 
8. I have morning stiffness of one hour  
or more.      0  1 2 3 4 5 6 
9. I have pain on motion of at least one joint. 0  1 2 3 4 5 6 
10. I cannot perform all the everyday tasks  
I normally would because of pain.   0  1 2 3 4 5 6 






11. Pain interferes with my sleep.   0  1 2 3 4 5 6 
12. I cannot decrease my pain by using  
methods other than taking extra medication.  0  1 2 3 4 5 6 
13. I would describe my pain as burning.  0  1 2 3 4 5 6 
14. I find that I guard my joints to reduce  
pain.       0  1 2 3 4 5 6 
15. I brace myself because of the pain.  0  1 2 3 4 5 6 
16. My pain is throbbing in nature.   0  1 2 3 4 5 6 
17. I would describe my pain as sharp. 0  1 2 3 4 5 6 
18. I would say my pain is severe.   0  1 2 3 4 5 6 
19. I feel stiffness in my joints after rest.  0  1 2 3 4 5 6 
20. My joints feel hot.    0  1 2 3 4 5 6 
21. I feel anxious because of pain.   0  1 2 3 4 5 6 
22. I would describe my pain as tingling.  0  1 2 3 4 5 6 
23. I feel my pain is uncontrollable.   0  1 2 3 4 5 6 
24. I feel helpless to control my pain.  0  1 2 3 4 5 6 
------------------------------------------------------------------------------------------ 
When looking at the scale below, overall I would rate my pain as: 
 
0  1  2  3  4  5  6  7  8  9  10 
 
NONE          SEVERE 
 
 




If I did not have diabetes… 
 






…I would enjoy my leisure activities  
very much more  much more  a little more   the same   less 
…My working life would be 
 very much better much better a little better  the same  worse 
…Local or long distance journeys would be 
 Very much easier much easier  a little easier  the same  more difficult 
…My holidays would be 
 very much better much better a little better  the same  worse 
…Physically I could do 
very much more  much more  a little more   the same   less 
…My family life would be 
 very much better much better a little better  the same  worse 
…My friendships and social life would be 
 very much better much better a little better  the same  worse 
…My closest personal relationship would be 
 very much better much better a little better  the same  worse 
…My sex life would be 
 very much better much better a little better  the same  worse 
…My physical appearance would be 
 very much better much better a little better  the same  worse 
…My self confidence would be 
 very much greater much greater a little greater  the same  less 
…My motivation would be 
 very much greater much greater a little greater  the same  less 
…The way people in general react to me would be 
 very much better much better a little better  the same  worse 
…My feelings about the future (e.g. worries, hopes) would be 
 very much better much better a little better  the same  worse 
…My financial situation would be  
 very much better much better a little better  the same  worse 






…My living conditions would be 
 very much better much better a little better  the same  worse 
…I would have to depend on others when I do not want to 
 Very much less much less a little less  the same  more 
…My freedom to eat as I wish would be 
 very much greater much greater a little greater  the same  less 
…My freedom to drink as I wish (e.g. fruit juice, alcohol, sweetened hot and cold drinks) would be 
 very much greater much greater a little greater  the same  less 
 
 
APPENDIX: Systemic Lupus 
 
LupusQoL Questionnaire The following questionnaire is designed to find out how SLE affects your life. Read each statement and 
then circle theresponse, which is closest to how you feel. Please try to answer all the questions as honestly as you can. 
 
How often over the last 4 weeks 
1. Because of my Lupus I need help to do heavy physical jobs such as digging the garden, painting and/or decorating, moving 
furniture 
All of the time  most of the time  a good bit of the time   occasionally   never 
2. Because of my Lupus I need help to do moderate physical jobs such as vacuuming, ironing, shopping, cleaning the 
bathroom 
All of the time   most of the time  a good bit of the time   occasionally  never 
3. Because of my Lupus I need help to do light physical jobs such as cooking/preparing meals, opening jars, dusting, combing 
my hair or attending to personal hygiene 
All of the time   most of the time  a good bit of the time   occasionally  never 
4. Because of my Lupus I am unable to perform everyday tasks such as my job, childcare, housework as well as 
I would like to 
All of the time   most of the time  a good bit of the time   occasionally   never 
5. Because of my Lupus I have difficulty climbing stairs 
All of the time   most of the time  a good bit of the time   occasionally   never 






6. Because of my Lupus I have lost some independence and am reliant on others 
All of the time   most of the time  a good bit of the time   occasionally   never 
7. I have to do things at a slower pace because of my Lupus 
All of the time   most of the time  a good bit of the time   occasionally   never 
8. Because of my Lupus my sleep pattern is disturbed 
All of the time   most of the time  a good bit of the time   occasionally   never 
 
How often over the last 4 weeks 
9. I am prevented from performing activities the way I would like to because of pain due to Lupus 
All of the time   most of the time  a good bit of the time   occasionally   never 
10. Because of my Lupus, the pain I experience interferes with the quality of my sleep 
All of the time   most of the time  a good bit of the time   occasionally   never 
11. The pain due to my Lupus is so severe that it limits my mobility 
All of the time   most of the time  a good bit of the time   occasionally   never 
12. Because of my Lupus I avoid planning to attend events in the future 
All of the time   most of the time  a good bit of the time   occasionally   never 
13. Because of the unpredictability of my Lupus I am unable to organise my life efficiently 
All of the time   most of the time  a good bit of the time   occasionally   never 
14. My Lupus varies from day to day which makes it difficult for me to commit myself to social arrangements 
All of the time most of the time a good bit of the time occasionally never 
15. Because of the pain I experience due to Lupus I am less interested in a sexual relationship 
All of the time  most of the time  a good bit of the time   occasionally   never   not applicable 
16. Because of my Lupus I am not interested in sex 
All of the time  most of the time  a good bit of the time   occasionally   never   not applicable 
17. I am concerned that my Lupus is stressful for those who are close to me 
All of the time   most of the time  a good bit of the time   occasionally   never 
18. Because of my Lupus I am concerned that I cause worry to those who are close to me 
All of the time   most of the time  a good bit of the time   occasionally   never 
19. Because of my Lupus I feel that I am a burden to my friends and/or family 
All of the time   most of the time  a good bit of the time   occasionally   never 







Over the past 4 weeks I have found my Lupus makes me 
20. Resentful 
All of the time   most of the time  a good bit of the time   occasionally   never 
21. So fed up nothing can cheer me up 
All of the time   most of the time  a good bit of the time   occasionally   never 
22. Sad 
All of the time   most of the time  a good bit of the time   occasionally   never 
23. Anxious 
All of the time   most of the time  a good bit of the time   occasionally   never 
24. Worried 
All of the time   most of the time  a good bit of the time   occasionally   never 
25. Lacking in self-confidence 
All of the time   most of the time  a good bit of the time   occasionally   never 
 
How often over the past 4 weeks 
26. My physical appearance due to Lupus interferes with my enjoyment of life 
All of the time   most of the time  a good bit of the time   occasionally   never 
 
27. Because of my Lupus, my appearance (e.g. rash, weight gain/loss) makes me avoid social situations 
All of the time   most of the time  a good bit of the time   occasionally   never 
28. Lupus related skin rashes make me feel less attractive 
All of the time   most of the time  a good bit of the time   occasionally   never 
 
How often over the past 4 weeks 
29. The hair loss I have experienced because of my Lupus makes me feel less attractive 
All of the time  most of the time  a good bit of the time   occasionally   never   not applicable 
30. The weight gain I have experienced because of my Lupus treatment makes me feel less attractive 
All of the time  most of the time  a good bit of the time   occasionally   never   not applicable  
31. Because of my Lupus I cannot concentrate for long periods of time 






All of the time   most of the time  a good bit of the time   occasionally   never 
32. Because of my Lupus I feel worn out and sluggish 
All of the time   most of the time  a good bit of the time   occasionally   never 
33. Because of my Lupus I need to have early nights 
All of the time   most of the time  a good bit of the time   occasionally   never 
34. Because of my Lupus I am often exhausted in the morning 
All of the time   most of the time  a good bit of the time   occasionally   never 
 
 
APPENDIX: Scleroderma, Dermatomyositis, Polymyositis, Wegener’s Granulomatosis 
 
World Health Organization Disability Assessment Schedule II Phase 2 Field Trials – Health Services Research 
36-Item Self-Administered Version  
 
H1 How do you rate your overall health in the past 30 days? 
Very good  Good   Moderate   Bad   Very Bad 
 
This questionnaire asks about difficulties due to health conditions. Health conditions include diseases or illnesses, other health 
problems that may be short or long lasting, injuries, mental or emotional problems, and problems with alcohol or drugs.Think back 
over the last 30 days and answer these questions thinking about how much difficulty you had doing the following activities. For each 
question, please circle only one response. 
 
In the last 30 days, how much difficulty did you have in: 
 
Understanding and communicating 
D1.1 Concentrating on doing something for ten minutes?  
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 
D1.2 Remembering to do important things?  
None   Mild    Moderate   Severe  Extreme/Cannot Do 







D1.3 Analyzing and finding solutions to problems in day to day life? 
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 
D1.4 Learning a new task, for example, learning how to get to a new place? 
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 
D1.5 Generally understanding what people say?  
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 
D1.6 Starting and maintaining a conversation?  
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 
Getting Around 
D2.1 Standing for long periods such as 30 minutes? 
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 
D2.2 Standing up from sitting down?  
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 
D2.3 Moving around inside your home?  
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 
D2.4 Getting out of your home?  
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 
D2.5 Walking a long distance such as a kilometer (or 
equivalent)? 
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 






In the last 30 days, how much difficulty did you have in: 
Self Care 
D3.1 Washing your whole body?  
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 
D3.2 Getting dressed?  
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 
D3.3 Eating? 
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 
D3.4 Staying by yourself for a few days?  
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 
Getting along with people 
D4.1 Dealing with people you do not know?  
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 
D4.2 Maintaining a friendship?  
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 
D4.3 Getting along with people who are close to you?  
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 
D4.4 Making new friends?  
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 
D4.5 Sexual activities?  
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 







D5.1 Taking care of your household responsibilities?  
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 
D5.2 Doing most important household tasks well?  
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 
D5.3 Getting all the household work done that you needed to do? 
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 
D5.4 Getting your household work done as quickly as needed? 
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 
IF YOU WORK (PAID, NON-PAID, SELF EMPLOYED) OR GO TO SCHOOL, COMPLETE QUESTIONS D5.5-D5.8 
BELOW. OTHERWISE, SKIP TO D6.1 AT THE TOP OF THE NEXT PAGE. 
 
In the last 30 days, how much difficulty did you have in: 
 
D5.5 Your day to day work/school?  
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 
D5.6 Doing your most important work/school tasks well? 
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 
D5.7 Getting all the work done that you need to do?  
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 
D5.8 Getting your work done as quickly as needed?  
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 






In the last 30 days: 
Participation in Society 
 
D6.1 How much of a problem did you have in joining in community activities (for example, festivities, religious or other activities) in 
the same way as anyone else can? 
None   Mild    Moderate   Severe  Extreme/Cannot Do 
D6.2 How much of a problem did you have because of barriers or hindrances in the world around you? 
None   Mild    Moderate   Severe  Extreme/Cannot Do 
D6.3 How much of a problem did you have living with dignity because of the attitudes and actions of others? 
None   Mild    Moderate   Severe  Extreme/Cannot Do 
D6.4 How much time did you spend on your health condition, or its consequences? 
None   Mild    Moderate   Severe  Extreme/Cannot Do 
D6.5 How much have you been emotionally affected by your health condition? 
None   Mild    Moderate   Severe  Extreme/Cannot Do 
D6.6 How much has your health been a drain on the financial resources of you or your family? 
None   Mild    Moderate   Severe  Extreme/Cannot Do 
D6.7 How much of a problem did your family have because of your health problems? 
None   Mild    Moderate   Severe  Extreme/Cannot Do 
D6.8 How much of a problem did you have in doing things by yourself for relaxation or pleasure? 
None   Mild    Moderate   Severe  Extreme/Cannot Do 
H2 Overall, how much did these difficulties interfere with your life? 
None   Mild    Moderate   Severe  Extreme/Cannot Do 
 
H3 Overall, in the past 30 days, how many days were these difficulties present? RECORD NUMBER OF DAYS ___/___ 
 
H4 In the past 30 days, for how many days were you totally unable to carry out your usual activities or work because of any health 
condition? RECORD NUMBER OF DAYS ___/___ 
 
H5: In the past 30 days, not counting the days that you were totally unable, for how many days did you cut back or reduce your usual 
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